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ABSTRACT
ANALYSIS OF THE INTRICACIES OF SUBSTRATE RECOGNITION OF HIGH
MOBILITY GROUP PROTEINS AND AMINOACYL-TRNA SYNTHETASES
USING NON-COGNATE SUBSTRATES
by Douglas Van Iverson II
August 2016
The studies presented in section 1 (Chapters I-IV) focus on the design and
development of nucleic acid four-way junctions (4WJs) to target a member of the
high mobility group (HMG) proteins, the proinflammatory cytokine high mobility
group box 1 protein (HMGB1). In the present study, hybrid PNA-DNA 4WJs
based on a model DNA 4WJ were constructed to improve the thermal stability of
4WJs while maintaining strong binding affinity toward HMGB1. An electrophoretic
mobility shift assay (EMSA) was used to examine the binding affinity of an
isolated DNA binding domain of HMGB1, the HMGB1 b-box (HMGB1b), toward a
set of PNA-DNA hybrid 4WJs. EMSAs showed that HMGB1b recognizes singlePNA hybrid 4WJs with a similar affinity to the DNA control. Circular dichroism
(CD) spectroscopy was used to examine the structure and monitor thermal
transitions of hybrid PNA-DNA four-way junctions in low (0.01mM Mg2+) and high
(2.00mM Mg2+) ionic strength environments. CD analysis suggests a large
deviation in helical structure between DNA and PNA hybrid junctions. Bluntended hybrid junctions b4WJ-PNA1 and b4WJ-PNA3 had higher melting
temperatures (Tms) than their full-length counter parts with Tms of 1.55 and
5.43C, respectively. Junction b4WJ-PNA3 was shown capable of binding
ii

HMGB1b with an affinity similar to that of its parent DNA junction and has a Tm of
41.18C, 1.14C higher than its parent DNA junction J1 and well above normal
body temperature, suggesting that b4WJ-PNA3 may be a viable therapeutic
agent for targeting HMGB1 in vivo.
In the study presented in section 2 (Chapters V-VIII), the amino acid (AA)
selectivity of aminoacyl-tRNA synthetases (aaRSs) was examined to investigate
a possible role for aaRSs in genetic code development. A radiometric assay was
used to perform an exhaustive survey of the 20 natural AAs vs. the 20 aaRSs
from Escherichia coli (E. coli). This study presents an AA chronology of Early vs.
Late AAs based on misactivation frequency. Findings were compared with
current theories on the evolution of AA recruitment and codification. The results
of this study show a correlation between misactivation frequency and the order of
AA codification, suggesting that aaRSs may have played a role in the process of
AA codification.

iii
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CHAPTER I – EXAMINING HYBRID PNA-DNA 4WJS AS POTENTIAL
THERAPEUTIC AGENTS TO TARGET THE PROINFLAMMATORY
CYTOKINE HMGB1
1.1 Synopsis and Hypotheses
Inflammation is part of the body’s response to injury or invasion and is a
necessary part of the innate immune system. However, uncontrolled
inflammation can cause damage to healthy tissue and exacerbate certain
diseases and disorders. The objective of the studies presented in Chapters I
through IV is to focus on the design and development of nucleic acid four-way
junctions (4WJs) to target the proinflammatory cytokine, HMGB1 in an effort to
reduce symptoms of inflammation. To date, there is no commercially available
treatment for HMGB1-linked disorders. The rational for selecting 4WJs as ligands
against HMGB1 is based on the multi-functional nature of the protein. HMGB1 is
an abundant DNA-binding protein that mediates nuclear homeostasis.1-7 It is now
clear that HMGB1 also functions in the extracellular matrix (ECM) as a cytokine
that initiates unintended leukocyte production.5,8-19 Due to the high cellular
abundance of HMGB1 (106 copies per cell), it is perhaps not surprising that it is
considered to be a biomarker and target for a variety of diseases and immune
disorders such: atherosclerosis8,18,19, lupus10,16,18, rheumatoid arthritis16,19,20, and
sepsis21,22. Consequently, a great deal of attention is focused toward targeting
HMGB1 in efforts to reduce the harmful effects of inflammation associated with
these conditions.

1

There is a need to develop novel therapeutics that target HMGB1 to treat
chronic inflammation through pathways that attenuate damage signals without
compromising the innate immune system. I hypothesize that immobile 4WJs
that mimic natural intracellular ligands of HMGB1, can: i) effectively target
the protein and ii) block harmful immune reactions. With a view to enhancing
the stability of 4WJs, certain DNA strands of 4WJs are replaced with the
nonstandard nucleic acid - peptide nucleic acid (PNA). I hypothesize that
hybrid PNA-DNA 4WJs possess enhanced thermal stability compared to
pure DNA 4WJs. Inflammation is often associated with fever. Therefore, any
therapeutic designed to traet inflammation will have to remain viable at elevated
body temperatures (>37°C). The rationale for choosing PNA as a DNA analogue
is based on studies that show duplex, triplex, and quadruplex structures
composed of PNA-DNA have Tms up to 30% higher than pure DNA structures
(69°C and 54°C for 15bp PNA-DNA hybrid and DNA duplexes, respectively).23-26
Chapter I of the document focuses on the background of HMGB1, 4WJs,
and PNA. The subsequent chapters focus on the design, development, and
structure of hybrid PNA-DNA 4WJs vs. the DNA 4WJ control, J1. Next, the
binding affinity of HMGB1b toward each hybrid 4WJ is evaluated. These data are
followed by a more detailed investigation of the conformational stability of each
hybrid 4WJ. Finally, the discussion presents hypotheses that describe the
possible connections between the structure of each hybrid 4WJ and its protein
recognition properties.

2

An electrophoretic mobility shift assay (EMSA) was used to examine the
binding affinity of HMGB1 toward the multi-PNA and blunt-ended hybrid
junctions. HMGB1b recognizes single-PNA hybrid 4WJs with similar affinity to the
DNA control, J1. All single-PNA hybrid junctions form 4:1 protein to junction
complexes at concentrations similar to that of J1. HMGB1b recognizes multi-PNA
hybrids but does not form stable 4:1 protein to junction complexes, as
represented by a single band in the absence of intermediate with the multi-PNA
substrates. CD spectroscopy was used to examine the structure and monitor
thermal transitions of hybrid PNA-DNA four-way junctions in low (0.01mM Mg2+)
and high (2mM Mg2+) ionic strength environments.
1.2 High Mobility Group (HMG) Proteins
HMG proteins are “architectural” nuclear proteins and the most abundant
class of non-histone nuclear proteins. Architectural DNA-binding proteins, unlike
transcription factors (TFs), do not bind in a sequence specific manner.27-29
Architectural nuclear proteins bind preferentially to certain structural DNA motifs.
One primary function of HMG proteins is to remodel chromatin. During this
process, HMG proteins bind/bend the topology of DNA within chromatin to
facilitate the binding of TFs to specific DNA sequences.1,28,30-32 TF binding
interactions in turn initiate gene expression. Hence, HMG proteins are generally
associated with gene expression vs. repression.1,3,27,33 HMG proteins also play
an expanded role in additional nuclear processes such as genetic recombination
and DNA repair.33,34

3

1.2.1 Classification of HMG proteins
HMG proteins are split into three categories: HMGA, HMGB, and HMGN.
Each protein class is distinguished by their respective DNA recognition
motifs.1,28,33-36 HMGA proteins contain three binding domains called AT-hook
motifs.35,36 The AT-hook sequences of HMGA proteins possess a conserved
PRGRP amino acid sequence. Two of the three AT-hooks are involved in DNA
recognition and binding.35 AT-hook motifs recognize the minor groove of duplex
DNA and induce bending.1,36 HMGN proteins affect the post-translational
modifications (i.e. acetylation and phosphorylation) of core histones and compete
with linker histone H1 to regulate chromatin structure.34,37 HMGN is also active in
DNA lesion repair.33,34,38 HMGN proteins possess the conserved sequence
RRSARLSA that serves as the DNA-binding region.38 The HMGB family of
proteins includes seven members: HMGB1, HMGB2, HMGB3, HMGB4, HMG1,
HMG2, and HMG2a.28 HMGB proteins’ functional DNA-binding motifs are
referred to as “box” domains. An HMG box domain is composed of three alpha
helices connected by short loops to form a HTH motif.1,6,28
1.2.2 High Mobility Group B1 (HMGB1)
HMGB1 is the most highly abundant (106 copies/cell) of HMGB proteins.
HMGB1 is composed of 215 amino acids that are arranged into three subunits,
two DNA-binding “box” domains and an acidic C-terminus.29 The a- and b-box
subunits from HMGB1 are displayed in Fig. 1 A and B, respectively. 39,40 DNA
binding occurs on the concave side of the L-shaped structure.39 This hydrophobic
face interacts with the minor groove of DNA. Two residues within the b-box,
4

Phe106 and Lys126 (shown in green in Fig. 1B), intercalate between DNA
strands. This induces an approximate 90° bend in the bound DNA strand.29,39
The a-box has only a single intercalating residue, Phe38, shown in green in Fig.
1A. The single intercalating residue of the a-box produces a less dramatic bend
in DNA of approximately 60°.29,40

A

B

Figure 1. HMGB1 a-box and b-box Structures
(A) Solution NMR structure of HMGB1 A-box domain from human highlighting DNA intercalating residue Phe38 [PDB:
2RTU]40. (B) Solution NMR structure HMGB1 B-box domain from rat highlighting DNA intercalating residues Phe106 and
Lys126 [PDB: 1HME]39.

1.2.3 Classical and Alternate Functions of HMGB1
Like other HMG proteins, HMGB1 was initially classified as a nuclear
protein. In the nucleus, HMGB1 binds preferentially to bent and cruciform DNA
(i.e. 4WJs) to control homeostatic functions such as chromatin remodeling and
5

genetic recombination and repair.2,41,42 With respect to chromatin remodeling,
HMGB1 binds DNA to induce bends that alter the topology of DNA.27,43 The bent
topology of DNA enhances TF binding at gene promoter regions. Moreover,
HMGB1 (like HMGN proteins) can displace histones from bent DNA and relax
structural constraints for transcription factor binding.3,43
Extracellular HMGB1 was initially discovered as a 30-kDa heparin-binding
protein in the developing brains of rats, and termed “amphoterin” before being
identified as HMGB1.5,11,44 HMGB1 was shown to be required for neuronal
outgrowth.44-46 Antibodies against HMGB1 were shown to inhibit neuronal
outgrowth in cell cultures.44,46 HMGB1 is localized in the filopodia extending from
the cell bodies of neurons and regulates outgrowth of axons and dendrites by
promoting adhesion of the growing membrane edges.44 HMGB1 was further
found to bind RAGE on the surface of rat embryonic cortical neurons, and is coexpressed with RAGE in developing rat neuroepithelium.46
HMGB1 has since been implicated in a variety of alternate cellular
processes such as: neuronal outgrowth, tumor proliferation, platelet activation,
cell adhesion, and as a mediator of immune response.5,9,12,15,17,30,31,41,44,46-54 The
role of HMGB1 in activation of immune response(s) has gained arguably the
majority of attention in recent years. With respect to the specific role of HMGB1
in immunity, HMGB1 acts as a redox- sensitive damage-associated molecular
pattern molecule (DAMP).17,18,49,53 HMGB1 can be released either actively by
immune cells or passively by damaged/necrotic cells (Fig. 3A).17,48 Active

6

HMGB1 release can be triggered by stimulation of macrophages and monocytes.
Passive release is normally associated with cellular injury.17,48,55
As stated earlier, posttranslational modifications influence the function of
HMGB1.5,9,18,48,52,56,57 The sequence for human HMGB1 is shown in Fig. 2.
HMGB1 can also function in the ECM as a damage associated molecular pattern
molecule (DAMP). In this capacity the oxidation state and posttranslational
modifications of the protein are critical.40,48,52 The key residues that undergo
modification are highlighted in Fig. 2 and include: Lys2, Lys11, Lys28, Lys29,
and Lys30 (acetylation sites highlighted maroon); Cys23, Cys45, and Cys106
(oxidation sites highlighted in dark blue); Ser35, Ser39, Ser42, Ser46, and Ser53
(phosphorylation sites highlighted in grey); and Lys43 (methylation site
highlighted in light blue).5,40,48
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Figure 2. HMGB1 sequence from human
The A-box shown in red text, B-box in blue text, and the acidic tail in green text. Acetylation sites (maroon), oxidation sites
(dark blue), DNA-binding (green), methylation (light blue) and phosphorylation (grey).

Acetylation of lysine residues in the A-box eliminates electrostatic
interaction of these residues with DNA and impedes binding.56 Acetylation of
these lysine residues in isolated A-boxes abolishes binding to DNA 4WJs. Upon
7

acetylation, the full-length protein retains its ability to bind 4WJs through
interactions with the B-box. In macrophages and monocytes, acetylation of lysine
residues in the A-box precedes cytosolic translocation of HMGB1.9,56
Phosphorylation then leads active secretion to the extracellular matrix by
lysosomes and secretion vesicles.48,52 In neutrophiles extra cellular transport is
induced through methylation of Lys42.18,48,52

Figure 3. Relationship between HMGB1 function and posttranslational
modifications
A) Active and passive HMGB1 release. B) HMGB1 oxidation states. From “The Role of High Mobility Group Box 1 in
Innate Immunity” by Lee, S.A. et. al.2014, Yonsei Med. J. 279, 20935-20940. Copyright 2014 by Yonsei University
College of Medicine. Reprinted under Creative Commons license.48
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The function of HMGB1 is dictated by its oxidation state (Fig. 3B).
HMGB1 is found in the nucleus in its fully reduced form.48,52 In damaged cells,
HMGB1 localizes within the cytosol. HMGB1 acts as a chemo-attractant in its
fully reduced form, enhancing autophagy and promoting lysosomal degradation
of damaged cellular components through interaction with the Beclin1-Bcl2
complex.50,52,54 Under oxidative conditions, Cys23 and Cys45 of the A-domain
form a disulfide bond. In the extracellular space disulfide-HMGB1 acts as a
proinflammatory cytokine.40,48,49 In this capacity, HMGB1 forms complexes with
or binds directly to immune receptors (Fig. 4) such as: chemokine (C-X-C Motif)
Ligand 12 (CXCL12), receptor for advanced glycation end products (RAGE), and
toll-like receptor (TLR)-4 to activate the nuclear factor kappa-B (NF-κB) pathway
and control leukocyte migration and activation.5,9,30 The complex formed between
HMGB1 and CXCL12 increases the affinity of CXCL12 for its receptor CXCR4
and promotes chemotaxis.5,18 Binding of HMGB1 to RAGE and TLR4 activates
the NF-κB pathway.12,16,51,58
Fully oxidized HMGB1 loses its immune function.5,48 The oxidation of
Cys106 has been shown to promote relocalization from the nucleus to the
cytoplasm in apoptotic cells and promotes immune tolerance.9,40,48,59 This
process is promoted by cellular reactive oxygen species (ROS). Caspase
activation targets the mitochondria to produce ROS during apoptosis. Cys106 is
oxidized by these mitochondrial ROS eliminating the proinflammatory activity of
HMGB1. This process has been shown to be necessary for neutralizing HMGB1
as a danger signal and promoting immune tolerance of apoptotic cells.60
9

Figure 4. HMGB1 extra nuclear interactions
HMGB1 binding to immune receptors RAGE and TLR4, and activation of CXCR4 through interaction with CXCL12 . From
“HMGB1 and leukocyte migration during trauma and sterile inflammation” by Venereau et al. 2013, Molecular Immunology
55, 76-82. Copyright 2013 by Elsevier. Reprinted with permission of the author.61

1.2.4 HMGB1 and Disease Pathogenesis
HMGB1 is gathering a great deal of attention as a disease biomarker and
therapeutic target. A growing number of studies link unintended HMGB1
signaling with pathogenesis in a number of diseases and immune disorders
(Fig. 5) such as: atherosclerosis8,18, diabetes62,63, lupus10,18, rheumatoid
arthritis16,18,20, and sepsis21,22,53. HMGB1 contributes to atherosclerosis by
promoting vascular inflammation and lesions.8 HMGB1 is found at elevated
levels in the blood plasma of patients with type 2 diabetes and is up regulated in
response to high glucose levels.62-64 HMGB1 promotes the production of
proinflammatory cytokines through activation of the NF-κB signaling pathway
exacerbating conditions such as diabetic neuropathy (DN).62
HMGB1 expression was shown to correlate with the severity of symptoms
of systemic lupus erythematosus (SLE) in mice.10 HMGB1 was shown to
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exacerbate renal pathology by enhancing macrophage inflammatory response
through activation of RAGE.10 Active HMGB1 release has been observed at sites
of joint inflammation in mice with arthritis. Injection of HMGB1 into the joints of
healthy mice induced arthritis in these locations.16,20
During the late phase of sepsis, HMGB1 release activates the coagulation
system and results in disseminated intravascular coagulation.22 HMGB1 secreted
from dying cells induces the release of additional HMGB1 and other cytokines
from macrophages and other cell types.22,50 HMGB1 has also been shown to
mediate acute lung injury and acute kidney injury during sepsis through activation
of the NF-κB pathway.21,22

Figure 5. HMGB1 and disease
From “Schmetterlingserythem bei systemischem Lupus” by Doktorinternet 2013, Wikimedia Commons. Copyright 2013 by
Doktorinternet. Reprinted under Creative Commons liscence. From “Myocardial Infarction or Heart Attack,” by Blausen
Medical Communications, Inc. 1997, Wikimedia Commons. Copyright 1997 by Blausen Medical Communications, Inc.
Reprinted under Creative Commons license. From “Chilblains, also called perniosis,” by Sapp 2007, Wikimedia
Commons. Copyright 2008 by Sapp. Reprinted under Creative Commons liscence. From “Front side of the left knee,” by
Stefan de Konink 2011. Wikimedia Commons. Copyright 2011 by Stefan de Konink. Reprinted under Creative Commons
liscence.
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1.2.5 Strategy to Target HMGB1
HMGB1 provides a target for novel therapeutics to treat chronic
inflammation through pathways that attenuate damage signals without
compromising the innate immune system. In mouse models with diabetes
HMGB1 inhibition reduced the up regulation of pro-inflammatory cytokines in
response to high glucose.62,63 In mouse models, antibodies against HMGB1 have
been shown to alleviate inflammation associated with rheumatoid arthritis and
prevent the progression of arthritis.20
Cell and animal model studies have found many pharmacologically active
compounds with the ability to suppress immune response by blocking HMGB1,
though many of these compounds were expensive, showed cytotoxicity at
required dosages, or have harsh side effects.12,20,49 Our strategy is to develop
cruciform nucleic acid structures (i.e. 4WJs) composed of DNA and PNA as
ligands against HMGB1. These hybrid PNA-DNA 4WJs mimic the natural DNA
4WJ ligands of HMGB1 in its role in genetic recombination. Several in vitro
studies show that HMG proteins bind 4WJs with binding constants at nM
range.66,67 Small (32bp – 28bp) 4WJs were developed to avoid immunogenicity
associated with larger DNA sequences.15,65 4WJs are also able to bind HMGB1
in 4:1 protein to junction complexes offering a distinct advantage over the single
binding sites of duplex structures. The hybrid 4WJs are based on the model
immobile DNA 4WJ, J1. J1 is composed of four asymmetric DNA strands that
ensure the lattice of the molecule is immobilized or “locked”. The long-term
objective is to reassign 4WJs to the ECM to target HMGB1. 4WJs are intended to
12

sequester HMGB1 and block unintended binding interactions between HMGB1
and immune receptors that initiate immune dysfunction. With respect to unnatural
substrates, PNA are used to replace DNA sequences within the lattice of J1 to
enhance the stability of the resulting hybrid DNA-PNA 4WJs.
We suspect that the binding affinity of HMGB1 toward 4WJs (Kd ≈ 10 –
160 nM) is strong enough to prevent HMGB1 binding to immune receptors.66,67
HMGB1 binds receptors such as RAGE and toll-like receptor 4 (TLR-4) with
binding constants that range from Kd ≈ 10.0 - 100.0 nM).46 Inhibition of HMGB1
by hybrid 4WJs is hypothesized to alleviate inflammation by scavenging HMGB1
from the ECM. This approach is designed to remove/prevent the interaction of
HMGB1 with RAGE and TLRs to effectively shut off immune responses.
1.3 DNA Four-Way Junctions
DNA 4WJs, also known as Holliday junctions, are key intermediate for
genetic recombination and double strand break repair.68,69 These processes are
essential to promoting genetic diversity and maintaining genomic stability. One of
the most extensive networks of Holliday junctions is found in the homologous
recombination (HR) steps of meiosis illustrated in Fig. 6. In the initial stage of
meiotic HR, double strand breaks (DSBs) are produced at numerous
chromosomal DNA sites to produce single strand 3’ overhangs. Next, DNA
recombinases bind the 3’ overhangs and search for an intact homologous dsDNA
sequence. The recombinases then promote strand invasion by the ssDNA ends
to form displacement loops. The initial strand invasion intermediates can be
processed by one of two pathways: rejoining of the broken strands by synthesis
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dependent strand annealing (SDSA) or by double strand break repair
(DSBR).69,70 The SDSA pathway results in displacement of the invading strand
and leads to non-crossover products. The DSBR pathway is the result of a more
stable strand invasion intermediate and leads to a second end capture. This
produces a double 4WJ that is eventually resolved to allow chromosome
segregation.68-72

Figure 6. Holliday junctions in genetic recombination.
Branch migration is required in genetic recombination in order to produce
crossover products. However, branch migration makes it difficult to probe the
structural dynamics of 4WJs. Hence, a great deal of effort was put forth to
assemble locked or “immobilized” 4WJs that form stable conformational
isomers.73,74 An algorithm developed by Seeman and Kallenbach, designed to
minimize sequence symmetry to ensure that the junction lattice is immobilized,
14

was used to devise a series of immobile 4WJs.73 The sequence identity of each
strand of J1 minimizes symmetry (to ensure that the junction lattice is
immobilized), while maintaining thermodynamic stability of the junction. The
algorithm is based on a set of rules that prevents: i) the repeat of four
consecutive nucleotides in any two strands and ii) the presence of complimentary
sequences in an arm and branch point.73,75,76 The sequence of the immobilized
junction J1 is displayed in Fig. 7.

Figure 7. Model immobile 4WJ J1
Individual strands are labeled as 101, 102, 103, AND 104, respectively.

Subsequent studies using a variety of biophysical techniques such as: gel
electrophoresis, chemical foot printing, enzymatic foot printing (protection
assays), fluorescence resonance energy transfer (FRET), nuclear magnetic
resonance (NMR), and X-ray studies reveal that the global conformation of 4WJs
fluctuate between extended or “open” structures and compact “stacked”
structures.77-81 The extended conformer, referred to as open-X, has four-fold
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symmetry (90 rotational symmetry) with all four arms pointing away from the
center (Fig. 8A). The compact or stacked-X isomers shown in Fig. 8B and C
possess two-fold symmetry (180 rotational symmetry) and can populate two
conformational isomers. Each stacked-X isomer contains two continuous strands
and two crossover strands. The continuous strands of the stacked-X isomers
have single axes throughout their respective helices. The crossover strands
switch helices at the branch or strand exchange point. Studies of J1 have shown
a preference for one of the isomers based on the sequences flanking the branch
point.75,76,82

Figure 8. Open-X vs. stacked-X conformational isomers
(A) The open conformer showing fully extended arms. (B) and (C) display the I/II and III/IV stacked-X conformers,
respectively.

The structure of 4WJs is highly dependent upon the concentration of
cations such as Na+ and Mg2+.81,83-85 Fig. 9 shows X-ray crystal structures of two
16

synthetic immobile 4WJs in the open-X (Fig. 9A)86, and in the stacked-X
conformation (Fig. 9B).87 In the absence of cations, electrostatic repulsion
between phosphates causes the helical arms to extend into the open-X
conformation (Fig. 9A). When the concentration of Mg2+ 100 μM, the charge
repulsion between negatively charged phosphate backbones is greatly reduced
promoting the transition from an open conformer to a stacked-X conformer.80,82,88

A

B

Figure 9. X-ray crystal structures of synthetic 4WJs
(A) X-ray crystal structure of a DNA 4WJ in an open conformation at a resolution of 2.8 Å [PDB: 1XNS] 86. (B) X-ray crystal
structure of a DNA 4WJ in a stacked-X conformation at a resolution of 1.94 Å [PDB: 4GQD]87.

The current studies focus on the immobilized 4WJ, J1. Electrophoresis
experiments confirmed that a 1:1:1:1 ratio of each strand of J1 forms a stable
complex.73,74 CD and NMR analyses revealed that 4WJs (including J1) posses BDNA helical structure.74,82,88,89 With respect to local heterogeneity within the
junction lattice, J1 (Fig 10A) was shown to prefer a stacking arrangement of arms
I/II - III/IV with strands 101 and 103 as the continuous strands and 102 and 104
as the crossover strands analogous to Fig. 9B.66,74,76,90 Examination of a J1
derivative, J2, with the CG and AT pairs at the branch point of arms III and IV
swapped revealed a much weaker preference for the I/II - III/IV isomer.89,90 Under
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conditions where J1 exists solely in the I/II - III/IV stacked-X isomeric form, J2
exists as a 5:1 mixture of the I/II - III/IV and I/IV - II/III isomers shown in Fig.
10B.89,90 Fig. 10C shows another J1 derivative, JEPS, with AT pairs replacing the
GC pairs at the ends of the junction arms. Studies utilizing FRET analysis
revealed that JEPS presented the same preference for the I/II - III/IV stacking
conformation as J1.78 It can be concluded from these studies that the bases at
the ends of the junction arms have little effect on the stacking arrangement while
the sequence near the branch point is a strong factor in determining the
preference for and stability of a particular structural isomer.78,89,90

Figure 10. 4WJ Isomerization
Each junction is shown in the open-X conformation at the top. The preferred stacked-X isomer is shown at the bottom. (A)
J1 shown to the left with a single preferred isomer. (B) J2 shown in the middle has no clear preference for a specific
stacked-X isomer. (C) JEPS shown to the right with its preferred stacked-X isomer.
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Therapeutics based on nucleic acids have shown moderate success in
targeting HMGB1. One study utilized DNA beads coated with DNA oligomers to
sequester HMGB1 in the intestines of mice after induction acute colitis. Oral
administration of the beads was shown to sequester HMGB1 from the gut and
reduce levels in serum samples.15 This study determined that larger DNA
constructs (i.e. 4WJs) show greater affinity for HMGB1 in vitro.15 However, the
4WJ constructs did not bind appreciably at low pH. I hypothesize that modifying
the 4WJ lattice by inserting more chemically stable nucleic acid analogs (i.e.
PNA) will produce enhanced in vivo stability. PNAs offer several properties that
make them ideal candidates for use as DNA analogs in 4WJs. PNAs form stable
hybrid structures with DNA through Watson-Crick base pairing. The global
conformations of PNA-DNA duplexes and 4WJs largely match the global
conformations of corresponding DNA structures. However, PNA-DNA structures
do show changes in local helical conformation compared to DNA structures. 91-95
The uncharged PNA backbone provides decreased charge repulsion between
strands, increasing the thermal stability of nucleic acid structures containing PNA
strands. This is evidenced by an increase in Tms of PNA-DNA hybrid duplexes
over their pure DNA counterparts by up to 30%.24,25,96 The peptide backbone of
PNA also provides nuclease resistance to hybrid structures.57,97
1.4 Nonstandard Nucleic Acid - Peptide Nucleic Acid (PNA)
PNAs are nucleic acid analogs that are composed of polyamide linkages
vs. sugar/phosphate bonds. PNAs were originally studied as gene-targeting
drugs that were designed to form complementary base pairs within gene
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regulating regions of DNA.98,99 PNAs contain standard nucleobases, however,
the sugar-phosphate backbone is replaced with an amide backbone composed of
aminoethyl glycine (AEG) units. AEG was selected as the original PNA backbone
based on computer models that show an AEG linkage provides a similar distance
between nucleobases as a sugar phosphate backbone. 98,99 Fig. 11 shows a
comparison of the functional units of PNA vs. DNA. PNAs contain the same
nucleobases as DNA or RNA. Therefore, PNAs form standard Watson-Crick
base pairs with PNA, DNA or RNA templates.100

A

B

Figure 11. DNA sugar phosphate backbone vs. PNA AEG backbone
(A) A sugar phosphate backbone unit of DNA. (B) An AEG backbone unit of PNA.

The polyamide backbone of PNA possesses several inherent structural
and biochemical advantages vs. DNA and RNA. The polyamide backbone of
PNA is not recognized by cellular nucleases making PNA more resistant to
digestion than DNA and RNA.57,97 The uncharged PNA backbone provides
decreased charge repulsion between strands, increasing the stability of nucleic
acid structures containing PNA strands.24,25,96 Studies examining 24 - 30bp DNA
and PNA-DNA duplexes showed higher Tm values for the PNA-DNA hybrids.
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DNA duplexes showed Tms between 47.8 and 53.5C with the corresponding
PNA-DNA hybrids displaying Tms between 61.8 to 68.5C.24,26 Corresponding
PNA-RNA duplexes showed even higher Tms up to 72.3C.24 Hence, hybrid PNADNA and PNA-RNA duplexes possess enhanced thermal stability vs. pure DNA
and RNA duplexes.24,25,85,96,100,101 These features have provided the impetus to
develop PNA-derived therapeutics or biotechnology reagents for many years.

Figure 12. Schematic of DNA/PNA duplex
Duplex obeys Watson-Crick hydrogen bonding rules in an antiparallel orientation.

As stated earlier, PNAs bind nucleic acids via Watson-Crick base pairing.
Thermal stability studies of hybrid duplexes showed them to be more stable in an
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anti-parallel orientation with the 3’ end of the DNA aligned with the N-terminus of
the PNA.24,100-102 Fig. 12 shows a schematic of a PNA-DNA duplex oriented in an
anti-parallel direction with a standard Watson-Crick hydrogen-bonding pattern.
Previous x-ray and NMR studies show that PNA duplexes can adopt
several discrete structures.91,92,94,103,104 These conformers come as a result of
rotation around the backbone amides, and transitions between them are slow,
reflecting the energy barrier between conformations resulting from the
coordinated motion required to avoid steric clashes.92,103 PNA-DNA duplexes,
however, showed only a single conformation.91,93,105 These hybrid duplexes show
structural alterations in both strands. PNA-DNA duplexes also show a slight
perturbation of base-stacking arrangement compared to the DNA/DNA
duplex.93,105 Fig. 13 shows x-ray crystal structures of DNA/DNA (A)106, PNA-DNA
(B)105, and PNA/PNA91 (C) duplexes. The structural similarities between
DNA/DNA and PNA-DNA duplex helicies are evident from Fig. 13. However,
PNA-DNA duplexes show a slight increase in the rise per bp (3.5 Å) compared to
B-form DNA duplexes (3.3Å).94 The results of previous structural studies suggest
that PNA-DNA hybrid structures adopt helical conformations that are quite similar
to DNA structures. These structural similarities no doubt facilitate the binding of
PNA-DNA hybrids to DNA binding proteins like HMGB1.
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Figure 13. NMR/X-ray Structures of Nucleic Acid Duplexes
(A) X-ray crystal structure of a DNA/DNA duplex at a resolution of 1.99 Å [PDB: 4HLI] 106. (B) NMR solution structure of a
PNA-DNA hybrid duplex [PDB: 1PDT]105. (C) X-ray crystal structure of a PNA/PNA91 duplex at a resolution of 1.7 Å [PDB:
1PUP]. DNA strands are shown in orange as cartoons. PNA strands are shown in green as stick structures.
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CHAPTER II - MATERIALS AND METHODS
2.1 Polyacrylamide Gel Electrophoresis (PAGE)
Nondenaturing PAGE has been used extensively to characterize DNA
4WJs. Junction formation is observed as a reduction in electrophoretic mobility of
the junction vs. single and double-stranded DNA.35,80,81,84,107-109 This technique
has also been used to observe changes in junction conformation in the presence
of metal ions such as Na+ and Mg2+.81,107,108 PAGE assays have also been used
to determine whether junctions show a preference for a particular stacked
isomer.80,107-109 In these studies, the junction arms were truncated by enzymatic
cleavage to generate multiple products that resemble either stacked-X or open-X
conformers. The resulting migration pattern(s) of the cleaved junctions are used
as controls to identify the mobility of stacked-X vs. open-X isomers of
uncharacterized junctions.81,108,109 These studies indicate that stacked-X
junctions migrate faster than open-X. The junctions investigated here all
presumably form stacked-X conformers based on the high level of Mg2+ (1 mM)
in the analysis buffer.
2.1.1 Four-Way Junction Formation
The sequences for J1 are: 101*, 5’-CGCAATCCTGAGCACG-3’; 102, 5’CGTGCTCACCGAATCG-3’; 103, 5’-GCATTCGGACTATGGC-3’ and 104, 5’GCCATAGTGGATTGCG-3’. The sequences for 4WJ-PNA1 are: PNA1, HCAATCCTGAGCA-K-NH2; 102, 5’-CGTGCTCACCGAATCG-3’; 103*, 5’GCATTCGGACTATGGC-3’ and 104, 5’-GCCATAGTGGATTGCG-3’. The
sequences for b4WJ-PNA1 are: PNA1, HCAATCCTGAGCA-K-NH2; b102, 5’24

TGCTCACCGAATCG-3’; 103*, 5’-GCATTCGGACTATGGC-3’ and b104, 5’GCCATAGTGGATTG-3’. The sequences for 4WJ-PNA3 are: 101*, 5’CGCAATCCTGAGCACG-3’; 102, 5’-CGTGCTCACCGAATCG-3’; PNA3: HATTCGGACTATG-K-NH2 and 104, 5’-GCCATAGTGGATTGCG-3’. The
sequences for b4WJ-PNA3 are: 101*, 5’-CGCAATCCTGAGCACG-3’; nb102, 5’CGTGCTCACCGAAT-3’; PNA3: H-ATTCGGACTATG-K-NH2 and 104, 5’GCCATAGTGGATTGCG-3’. The sequences for 4WJ-PNA1,3 are: PNA1,
HCAATCCTGAGCA-K-NH2; 102, 5’-CGTGCTCACCGAATCG-3’; PNA3: HATTCGGACTATG-K-NH2 and 104*, 5’-GCCATAGTGGATTGCG-3’. The
sequences for b4WJ-PNA1,3 are: PNA1, H-CAATCCTGAGCA-K-NH2; db102, 5’TGCTCACCGAAT-3’; PNA3: H-ATTCGGACTATG-K-NH2 and bf104*, 5’CATAGTGGATTG-3’. Strands labeled with fluorescein are denoted with an
asterisk (101*, 103*, nb104* and bf104*). Each fluorescent strand was purified
via HPLC; each non-labeled DNA strand was purified via denaturing
polyacrylamide gels. All DNA was purchased from Integrated DNA Technologies
(IDT). Junctions were formed by mixing 25M of a fluorescein labeled strand with
125M of each unlabeled strand. This mixture was lyophilized and resuspended
in an annealing buffer consisting of 50 mM Tris-HCl (pH 7.5) and 1.0 mM MgCl2.
The reconstituted strands are then incubated at 95°C for 2 min, followed by
cooling to room temperature for 12-16 h. The 4WJs were loaded onto 15% miniPROTEAN native polyacrylamide gels (BioRad) and run for 1-5 h at 4°C. The gel
running buffer was composed of 0.5 X TBE (MgCl2 buffer (45 mM Trisma, 45 mM
boric acid, 1.0 mM EDTA and 1 mM MgCl2), pH 7.6. The gels were subsequently
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scanned with a Typhoon 9400 Phosphorimager in fluorescence mode at 530 nm
using an excitation wavelength of 488 nm and a light pollution filter blocking
wavelengths below 510 nm. Gels were scanned at PMT settings that ranged
between 400 and 800.
2.1.2 Electrophoretic Mobility Shift Assays (EMSAs)
EMSAs are used to examine the protein recognition properties of the
hybrid 4WJs toward the recombinant DNA binding protein, HMGB1b. The binding
affinity of the previously uncharacterized junctions: b4WJ-PNA1, b4WJ-PNA3,
4WJ-PNA1,3 and b4WJ-PNA1,3 are evaluated with HMGB1b. A constant 4WJ
concentration of 500nM was used with HMGB1b:4WJ molar ratios ranging from
3.2:1 (1.6

are evaluated with HMGB1b. A constant 4WJ concentration of

500nM was used with HMGB1b:4WJ molar ratios ranging from 3.2:1 (1.6 1b.
composed of 0.5 X TBE (MgClDNA s2 and 10% (w/v) glycerol. Each sample is
loaded onto 15% Mini-PROTEAN TBE precast native polyacrylamide gels
(BioRad). Gels are run at 4°C in a 0.5 X TBE buffer composed of 45 mM Trisma,
45mM boric acid, 1.0mM EDTA and 1mM MgCl2 (pH 7.6) for 6-8 h. The gels
were subsequently scanned with a Typhoon 9400 Phosphorimager. Each EMSA
represents at least three independent runs/junction.
2.2 Circular Dichroism (CD) Analysis of Nucleic Acids
2.2.1 CD Analysis of Classic Nucleic Acids
The CD signal of nucleic acids arises from the stacking geometries of the
bases.110-112 Differences in CD spectra of A- and B-DNA arise from the
respective conformations of the backbone sugar moiety.110,112 Fig. 14 shows a
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diagram of the two isomers. The deoxyribose and ribose sugars of A-DNA and
RNA have an endo pucker at the C3’ position while the deoxyribose sugar of BDNA has an endo pucker at the C2’ position.110

Figure 14. Differences in the endo pucker of DNA deoxyribose sugar A- and BDNA structures.
From “Circular dichroism techniques:biomolecular and nanostructural analyses- a review,” by Ranjbar et al. 2009, Chem.
Biol. Drug Des. 74, 101-120. Copyright 2009 by John Wiley and Sons. Reprinted with permission of the author.110

A consequence of this isomerization is a shift in the helical structure. Fig.
15 displays 3D-models of A- and B-DNA. A-DNA, shown in Fig. 15A, has a much
narrower major groove and wider minor groove compared to B-DNA. Fig. 15B
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shows the more common B-DNA structure with a wide major groove and narrow
minor groove. These changes give rise to the differing CD spectra of A- and BDNA shown at the bottom of Fig. 14. The spectrum for B-form DNA is shown at
the bottom right of Fig. 14. The B-DNA spectrum contains characteristic positive
and negative bands near 280nm and 240nm, respectively. These peaks are
usually comparable in shape and magnitude. Smaller positive and negative
absorption bands near 220nm and 205nm, respectively, are also commonly
observed. The spectrum of A-form DNA is shown at the bottom left of Fig. 14
shows a strong negative peak at 205nm and a strong positive near at
270nm.110,112,113

Figure 15. Example DNA duplex structures
(A) B-DNA shown in red. (B) A-DNA shown in blue.

The CD spectra of duplex DNA most commonly display a B-DNA pattern.
However, deviations from the classical B-DNA conformation have been
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observed, especially under dehydrating conditions.112,114,115 Analyses of DNA
three way junctions (3WJs) have shown the global conformation of the junction
can affect the helical structure of the junction arms. Changes in the stacking
arrangement of 3WJs have been shown to promote transition from a B- DNA
conformation to a more A- DNA helical conformation. CD spectra of these
junctions produced a strong negative peak near 210nm, indicative of ADNA.114,115
CD spectroscopy can also be used to characterize DNA 4WJs. Like DNA
duplexes, DNA 4WJs typically show a strong preference for B-like helical
conformations.74,75,89,96,103 CD spectroscopy has also been used to show that the
sequences flanking the junction branch point have a large impact on the global
conformation of 4WJs.75,78,90 Junctions with branch points capable of migrating
along the arms are termed “mobile”, while those with branch points locked into
place are termed “immobile”. Immobile junctions contain asymmetric sequences
only capable of pairing in a single configuration. CD studies were essential to
confirm PAGE analysis of mobile vs. immobile DNA 4WJs. Mobile and immobile
4WJ differ by the positions of the bases at the junction branch point. Immobile
4WJs tend to possess more GC bases at the junction branch point to help
immobilize or lock the junction lattice.73-76,89 The CD studies show that the
repositioning of GC and AT bp at the junction branch point of 4WJs produced a
blue shift and decrease in intensity in the peak near 280nm indicating a shift in
structure.75 These sequence changes presumably contribute to the loss of
stability of the preferred isomerization state.75,78,90
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2.2.2 CD Analysis of PNA
The polyamide backbone of PNA is achiral and does not produce a CD
signal. However, incorporating chiral molecules into the backbone can induce
handedness of single PNA strands and duplexes.95,99,103,104,116,117 The chiral
moiety can be placed at either PNA terminus 95,103,104,116 or internally 103,117.
Examination of a variety of AAs showed Lys to be an efficient promoter of PNA
helix handedness95,103,116, while also improving PNA solubility99. To date, all
studies indicate that, when attached to a PNA, L-AAs produce left-handed
helices and D-AAs generate right-handed helices.95,103,104,116,117 The direction and
magnitude of PNA handedness are based on a combination of factors such as: i)
the identity of the AA side chain, ii) the stereochemistry of the AA, iii) the position
of the AA within the PNA backbone and iv) the sequence of the final nucleotides
attached to the AA.95,103,104,116,117 Attaching the chiral ligand to the C-terminus
was also shown to more efficiently induce handedness in PNA helices.95 Lys
attached to a C (C-Lys) was shown to produce a much more intense CD signal
than A-Lys or T-Lys. G-Lys produced a weak signal corresponding to a structure
of opposite helicity from C-, A-, and T-Lys.95
With respect to the analysis of PNA-DNA hybrid structures, the strength of
signal is based predominantly on the presence of chiral DNA strand. PNA-DNA
duplexes always form right-handed helices regardless of the conformation of the
unbound PNA strand.100,103,117 CD analysis showed PNAs exhibiting right-handed
character to bind DNA in an anti parallel fashion, while those exhibiting lefthanded character bind in a parallel fashion.103,117
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2.2.3 CD Thermal Denaturation Analysis
Ultraviolet (UV) and CD spectroscopy have been used extensively to
examine thermal denaturation and structural transitions of nucleic acid
structures.26,66,75,84,85,92,96,101,104,112,114,115,118-122 These studies yield data on the
relative stabilities of nucleic acid structures, usually given as a melting
temperature (Tm). These studies allow the determination of cooperativity in
melting and the presence of two-state or gradual transition.24,26,112,113,123
By normalizing the upper and lower baselines of the melting curves to 1
and 0, respectively, the Y-axis can be redefined to reflect the fraction of
DNA/PNA strands in junction form (α). The value of α directly reflects the fraction
strands in junction form. Therefore, at the Tm, α is equal to 0.5. Differentiating the
melting curves yield plots of δα /δT vs. T, where δα /δT is the change in fraction
of DNA/PNA strands in junction form over change in temperature and T is
temperature. Calculation of van’t Hoff enthalpies (ΔHVH) was done using the
equation below:
Eq. 1
Eq. 1 was derived from a more general form of van’t Hoff’s equation to
extract thermodynamic data for tetramolecular processes such as 4WJ formation
and yields van’t Hoff transition enthalpies (ΔHVH) at the Tm.24,26,121,123
Alternatively, ΔHVH was calculated using the full width (Eq. 2) and half width (Eq.
3) of the differentiated melting curve at the half-height.24,123 The following two
general forms of van’t Hoff’s equation are used for these calculations:

31

Eq. 2

Eq. 3

Both B and B’ are association reaction constants for polynucleic acids that
depend on the molecularity (n) (i.e. the number of strands) of the process and
are in units of cal/mol-K. B is used for the calculation of ΔHVH using the full width
(T1 to T2) of the melt curve first derivatives. B’ is used for the calculation of ΔHVH
using the half width (Tmax to T2) of the melt curve first derivatives. Values for B
and B’ are 15.40 and 5.63 cal/mol-K, respectively, reported in previous work by
Marky and Breslauer.123
Rescaling the melting curve still yields an X value at the minima (Tmin)
corresponds to the Tm. The Y value at the minima or Tm is δα /δTm. These values
for Tm and δα /δTm can be plugged into Eq. 1 to yield ΔHVH. Alternatively, values
for T1 and T2 taken at (δα /δT)0.5 can be plugged into Eq. 2 to yield ΔHVH. A third
method used to calculate ΔHVH (Eq. 3) relies on Tm and T2 taken at (δα
/δT)0.5.24,123
2.2.4 CD Spectroscopy of 4WJs
CD spectra were recorded using Jasco J-815 spectrometer. A 2.0 μM
solution of each 4WJ was prepared in CD analysis buffer: 20 mM HEPES, 30mM
NH4Cl, 200 mM KCl, 2 mM DTT, and 10% glycerol. The low Mg2+ CD buffer
contained 100 μM MgCl2; the high Mg2+ CD buffer contained 2 mM MgCl2. All
spectra were measured in a 0.1 cm path-length quartz cuvette; spectra were
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recorded from 320 to 200 nm in 1.0 nm increments at 4°C. The thermal
denaturation profile of each 4WJ was monitored under the same buffer
conditions (low and high Mg2+) at a fixed wavelength (maxima near 275 nm) from
4 to 100°C. The Tm values were calculated by the fitting the average value of at
least three independent scans to a sigmoidal curve equation using GraphPad ©..

33

CHAPTER III - RESULTS
3.1 PAGE Analysis of Native and Hybrid PNA-DNA 4WJs
The six hybrid PNA-DNA 4WJs being investigated for HMGB1b binding
capacity are shown in Fig. 16, along with the DNA control J1. EMSAs were used
to examine the protein recognition properties of the hybrid 4WJs toward the
recombinant DNA binding protein, HMGB1b. Each hybrid 4WJ contains PNA
strand(s) at the 101 and/or 103 positions (Fig. 10). Strands 101 and 103,
representing the continuous strands of the J1 stacked-X conformer, were
selected as the initial replacement strands. Future studies will focus on replacing
strands 102 and 104.
PNA length was limited to 12 residues in order to mitigate problems
associated with synthesis of longer PNA sequences. As a result, certain hybrids
(4WJ-PNA1, 4WJ-PNA3, and 4WJ-PNA1,3) have DNA strands that are 4
nucleotides longer than the corresponding PNA strands. Our initial report
showed that the presence of DNA overhangs did not prohibit the formation of
4WJ-PNA1, 4WJ-PNA3.66 However, the free motion of these DNA overhangs may
result in structural instability of the hybrid junctions. Here the effects of truncating
these DNA overhangs were investigated. Hybrid junctions b4WJ-PNA1, b4WJPNA3, and b4WJ-PNA1,3, shown at the bottom of Fig. 16, contain truncated DNA
sequences in positions complementary to PNA strands. DNA sequences were
truncated to match the length of PNA sequences, producing blunt-ended junction
arms.
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Figure 16. Diagram of Hybrid 4WJs
From top left: J1, 4WJ-PNA1, 4WJ-PNA3, 4WJ-PNA1,3, b4WJ-PNA1, b4WJ-PNA3, and b4WJ-PNA1,3

Gel electrophoresis was used to confirm junction formation. Stable 4WJ
formation is evidenced by a significant reduction in electrophoretic mobility of the
junction compared to single strands of DNA. Fig. 17 illustrates the differences in
mobility between the 101 strand (lane 1) and junctions (lanes 2-9). J1 is loaded
in lanes 2 and 9 to give a more accurate comparison of electrophoretic mobility of
each hybrid vs. the control. Despite the reduction in charge from their peptide
backbones, each single PNA hybrid 4WJ (Fig. 17 lanes 3-6) showed migration
patterns similar to J1. The multi PNAs (Fig. 17 lanes 7 and 8), with a substantial
reduction in charge, showed only a slight reduction in mobility. PAGE analysis
showed the multi PNA hybrids migrate approximately 90 - 95% the distance of J1
and the single-PNA constructs. These results match those of previous studies
that showed electrophoretic mobility of hybrid junctions to be a function of size
and conformation, with little effect from the reduction in charge due to the PNA
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backbone.81,107,124 Studies have shown that the difference in electrophoretic
mobility of PNA-DNA triplexes was strongly dependent on the shape of the
triplex.124 More specifically, triplexes that possessed a significant bend migrated
more slowly than linear triplexes. The 4WJs examined here migrate together due
to similarities in size (24-32bp) and global conformation (stacked-X). High
mobility bands present in the PNA1 constructs (Fig. 17 lanes 3 and 4) were an
area of concern as they may be the result of contaminating structures (i.e.
duplexes or triplexes) that promote the assembly of larger structures (i.e. non4WJ tetramolecular DNA assemblies containing multiple copies of one or two
strands) that mimic the electrophoretic mobilities of 4WJs. A series of controls
were devised (Fig. 18-20) to test each junction for the presence of higher order
contaminating structures composed of two and three strand combinations.

Figure 17. Nondenaturing Polyacrylamide Gel of Hybrid 4WJs.
Lane 1) 101, 2) J1, 3) 4WJ-PNA1, 4) b4WJ-PNA1, 5) 4WJ-PNA3, 6) b4WJ-PNA3, 7) 4WJ-PNA1,3, 8) b4WJ:PNA1,3 and 9)
J1.
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The data in Fig. 18 - 20 display the electrophoretic mobility patterns of six
hybrid PNA–DNA 4WJs vs. i) J1 and ii) different combinations of potentially
contaminating strands of DNA. Fig. 18 shows 4WJ-PNA1 and b4WJ-PNA1. Fig.
19 shows 4WJ-PNA3 and b4WJ-PNA3. Fig. 20 shows 4WJ-PNA1,3 and b4WJPNA1,3. The contaminating strands are composed of single strands used to form
J1. The data are based on the protocol used by Seeman and Kallenbach to
characterize, J1.73 The data provides a direct method to compare the mobility of
immobile hybrid PNA–DNA junctions vs. a DNA control junction (J1) and
potentially contaminating multi-PNAs. In each gel (Fig. 18 - 20), the single strand
control (101) is loaded in lane 1; the different single strand combinations are
loaded in lanes 2–11; the DNA control, J1 is loaded in lane 12, and the hybrid
PNA–DNA junctions are loaded in lanes 13 and 14.

Figure 18. Formation Controls for 4WJ-PNA1 and b4WJ-PNA1
Lanes 1-14: 1) 101*, 2) 101*-102, 3) 101*-103, 4) 101*-104, 5) 102-103*, 6) 102-104*, 7) 103-104*, 8) 101*-102-103,
9) 101*-102-104, 10) 101*-103-104, 11) 102-103-104*, 12) J1(101*), 13) 4WJ-PNA1(103*), and 14) b4WJ-PNA1(103*).
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Figure 19. Formation Controls for 4WJ-PNA3 and b4WJ-PNA3
Lanes 1-14: lanes 1-14: 1) 101*, 2) 101*-102, 3) 101*-103, 4) 101*-104, 5) 102-103*, 6) 102-104*, 7) 103-104*, 8) 101*102-103, 9) 101*-102-104, 10) 101*-103-104, 11) 102-103 104*, 12) J1(101*), 13) 4WJ-PNA3(101*), and 14) b4WJPNA3(101*).

Figure 20. Formation Controls for 4WJ-PNA1,3 and b4WJ-PNA1,3
Lanes 1-15: lanes 1-14: 1) 101*, 2) 101*-102, 3) 101*-103, 4) 101*-104, 5) 102-103*, 6) 102-104*, 7) 103-104*, 8) 101*102-103, 9) 101*-102-104, 10) 101*-103-104, 11) 102-103 104*, 12) J1 (101*), 13) 4WJ-PNA1,3(104*), and 14) b4WJPNA1,3(bf104*).
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The electrophoretic mobilities of J1 and the hybrid junction bands (Fig. 18
- 20 lanes 12-14) are significantly reduced compared to bands seen with the
double and triple DNA strand combinations (Fig. 18 - 20 lanes 2 - 11 ). Double
and triple strand combinations in lanes 2, 7, 8, 9, and 10 from each analysis
representing combinations of 101-102, 103-104, 101-102-103, 101-102-104, and
101-103-104, respectively, display bands that run slower than the 101 strand
control (lane 1) but faster than the junction bands in lanes 12 - 14. These bands
likely represent duplex or possibly triplex structures. Fig. 18 - 20 show that none
of the double and triple strand combinations shown in lanes 2 - 11 form species
that run with the same mobility as bands representing the 4WJs in lanes 12 - 14.
These results display indirectly that the duplex and triplex structures do not
aggregate to form contaminating structures that run with the same
electrophoretic mobility as immobilized 4WJs. Instead, it seems that immobilized
junctions merely dissociate to a certain extent during gel analysis. High mobility
bands seen in lanes 2 - 9 of Fig 17 then represent single strand and duplex
and/or triplex structures and low mobility bands represent 4WJs.
3.2 HMGB1 Binding
EMSAs were used to evaluate the binding affinity of b4WJ-PNA1, b4WJPNA3, 4WJ-PNA1,3 and b4WJ-PNA1,3 toward the recombinant DNA binding
protein, HMGB1b. Fluorescence binding and analytical ultracentrifugation
analysis from previous studies have shown that HMGB1b binds J1 with a
stoichiometry of four to one (4:1), presumably favoring the open configuration. 67
Previous EMSA studies were used to measure the binding constants of 4WJ39

PNA1 and 4WJ-PNA3 toward HMGB1b.66 Both 4WJ-PNA1 and 4WJ-PNA3 formed
4:1 complexes that migrate as single bands without intermediate binding species.
Previous studies suggest that hybrid junction 4WJ-PNA3 binds HMGB1b with a
nearly identical affinity to J1 (Kd ≈ 6.0 M).66 Previous studies suggest that the
binding affinity of HMGB1b for 4WJ-PNA1 was only slightly less than that of J1
(Kd ≈ 16.0 M).66 The current study examines the HMGB1b binding properties of
four additional hybrid junctions, b4WJ-PNA1, b4WJ-PNA3, 4WJ-PNA1,3, and
b4WJ-PNA1,3. The DNA overhangs have been truncated from 4WJ-PNA1 and
4WJ-PNA3 to produce the blunt-ended junctions b4WJ-PNA1 and b4WJ-PNA3,
respectively. The multi-PNA junctions 4WJ-PNA1,3 and b4WJ-PNA1,3 each
contain two PNA strands. The b4WJ-PNA1,3 hybrid is the smallest of the 4WJs
examined, with truncated DNA sequences at the end of each arm. These new
hybrids were developed in an effort to increase the thermal and nuclease stability
of 4WJs. However, these changes to the DNA strand sizes and junction PNA
content may affect HMGB1 binding affinity. EMSAs were used to examine the
binding affinity of b4WJ-PNA1, b4WJ-PNA3, 4WJ-PNA1,3 and b4WJ-PNA1,3
toward HMGB1b in order to understand the effects of removing DNA overhangs
and adding an additional PNA strand on the protein recognition properties of
hybrid 4WJs toward the recombinant DNA binding protein, HMGB1b.
The EMSA data is displayed in Fig. 21. Panels A-E represent: J1, b4WJPNA1, b4WJ-PNA3, 4WJ-PNA1,3 and b4WJ-PNA1,3. The protein and junction are
expressed in terms of molar ratio of protein to junction (P/J). Lane 1 corresponds
to 0.05 mM of 4WJ, lanes 2-8 represent each 4WJ incubated with each protein at
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P/J ratios of 3.2:1, 6.4:1, 12.8:1, 25.6:1, 47.8:1, 63.4:1 and 79:1. Fig. 21A shows
initial binding of HMGB1b to J1 in lane 3 at a ratio of 6.4:1. Complete binding of
HMGB1b to J1 is achieved by lane 4 at a P/J ratio of 12.8:1. Fig. 21B shows
HMGB1b binding to b4WJ-PNA1 with affinity similar to J1. Initial binding
interactions with b4WJ-PNA1 again take place at a P/J ratio of 6.4:1 (lane 3).
Complete binding of HMGB1b to b4WJ-PNA1 is seen in lane 4 at a P/J ratio of
12.8:1. In Fig. 21C HMGB1b was shown to bind b4WJ-PNA3 with a slightly lower
affinity than J1 and b4WJ-PNA1. Initial binding of b4WJ-PNA3 takes place at a
P/J ratio of 12.8:1 (lane 4), and complete binding of HMGB1b to b4WJ-PNA3 is
achieved at a P/J ratio of 25.6:1 (lane 5). The multi-PNA hybrids, 4WJ-PNA1,3
and b4WJ-PNA1,3 are shown in Fig. 21D and E. HMGB1b showed similar binding
patterns with 4WJ-PNA1,3 and b4WJ-PNA1,3. Both 4WJ-PNA1,3 and b4WJ-PNA1,3
EMSAs show the appearance of broadened/smeared bands.with increasing
HMGB1b concentration, indicative of the formation of unstable protein/junction
complexes that dissociate under experimental conditions. Initial HMGB1b binding
is evidenced by the appearance of smeared bands at P/J ratios of 12.8:1 for
4WJ-PNA1,3 (Fig. 21D, lane 5) and 24:1 for b4WJ-PNA1,3 (Fig. 21E, lane 6). The
smeared bands continue to broaden as the P/J molar ratio increases out to 79:1
(lane 8) indicating an increase in junction binding. However, complete binding of
4WJ-PNA1,3 and b4WJ-PNA1,3 is never achieved.
Previous binding studies show that HMGB1b has a similar binding affinity
for J1 and hybrid junctions 4WJ-PNA1 and 4WJ-PNA3. The EMSA results of the
current study suggest that the blunt-ended hybrid junctions b4WJ-PNA1 and
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b4WJ-PNA3 also bind HMGB1b with a similar affinity to J1. This result suggests
that truncating the DNA overhangs did not adversely affect the HMGB1b binding
capacity of hybrid 4WJs, and demonstrates the therapeutic potential of these
new constructs as ligands for HMGB1. The multi-PNA hybrid junctions, 4WJPNA1,3 and b4WJ-PNA1,3 do not form stable complexes and are not expected to
be viable therapeutic ligands for HMGB1.

Figure 21. EMSA of HMGB1b binding
A) J1 and novel hybrid junctions B) b4WJ-PNA1, C) b4WJ-PNA3, D) 4WJ-PNA1,3 and E) b4WJ-PNA1,3. Lanes 1-8 of each
panel contain protein/DNA ratios of 1) 0:1, 2) 3.2:1, 3) 6.4:1, 4) 12.8:1, 5) 25.6:1, 6) 47.8:1, 7) 63.4:1 and 8) 79:1,
respectively.
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3.3 CD Analysis of Hybrid 4WJs
B-form and A-from DNA possess different CD spectra. The spectra of Bform DNA show positive bands at 280nm and negative bands at 250nm that are
roughly symmetrical. A-form DNA show a characteristic negative band at
~205nm and a strong positive band between 260 and 270nm. Fig. 22A and B
show comparisons of CD spectra of J1 and the hybrid 4WJs in low (0.01mM) and
high (2mM) concentrations of Mg2+ ion. The 2mM Mg2+ ion concentration was
chosen to correspond with the high end of the standard ECM Mg2+ ion
concentration range of 1mM – 2mM.125 CD spectra of the hybrid 4WJs are quite
different from that of J1. Spectra of the hybrid 4WJs show positive bands
between 265 and 278nm are blue shifted and lower in intensity compared to
those of J1. These positive bands displayed a lack of symmetry with negative
bands centered at 250nm in all hybrid 4WJ spectra. Hybrid junctions also
showed an intense peak near 205nm under both sets of conditions. The lack of
symmetry in the bands between 250 and 280nm and the presence of the peaks
at 205nm are highly indicative of a shift toward more A-form conformation. These
shifts were more pronounced in the case of the multi PNA constructs.
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Figure 22. CD spectra of 4WJs in low (~0.01mM) and high (2mM) Mg2+
CD spectra highlighting A- and B-form signals for J1 vs. single-PNA and multi-PNA 4WJ in low and high Mg2+. Panel A)
represents each single- and multi-PNA hybrid vs. J1 in low Mg2+. Panel B) represents each single- and multi-PNA hybrid
vs. J1 in high Mg2+.

CD spectra can be used to effectively examine the relative contribution of
A and B form helical character to the overall spectra. This is done by examining
signals at 205 and 250nm. The ratio between the magnitudes of the two peaks
yields the apparent fraction of A and B form helices.78,94,114,115 Fig. 23 shows the
apparent fraction of A (AFA) and B (AFB) form helices determined for each
junction in high and low Mg2+. The DNA control J1 displayed AFB values
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exceeding 0.85 in both low and high Mg2+ denoting its predominantly B-form
character.
Hybrid junctions all showed a propensity for higher fractions (0.5-0.95) of
A-form helices in the absence of Mg2+. Single PNA b4WJs showed a propensity
for greater B-form character than their full-length counterparts. All single PNA
hybrids displayed considerable structural sensitivity to Mg2+ concentration. In the
presence of 2mM Mg2+ all single PNA hybrids shifted to higher AFB with the
greatest shift seen for b4WJ-PNA3 (0.5 to 0.9 AFB). The multi PNA hybrids
possessed the highest AFA. The structure of the multi PNA hybrids was largely
unaffected by Mg2+ concentration, retaining <0.9 AFA under both sets of
conditions. The signals between 265 nm and 280 nm are excluded because they
are common to both A- and B-form conformers. The hatched bars represent
helical fractions calculated in low Mg2+; the solid bars represent fractions
calculated in high Mg2+.

Figure 23. Apparent fraction of B- and A-form DNA
(A) B-form DNA and (B) A-form DNA of each junction in low and high Mg2+
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The FB value of each single- PNA construct increases in high Mg2+ (solid
bars); three of four hybrids possess AFB values > 0.5. The secondary structure of
the PNA3 derived hybrids proved more sensitive to Mg2+ than PNA1 derived
hybrids, again illustrating the sequence dependence of hybrid structure and
stability. 4WJ-PNA3 and b4WJ-PNA3 display an approximate 2-fold increase in Bform content in high Mg2+, with the AFB value for b4WJ-PNA3 being nearly
identical to J1. The large AFA values (> 0.9) for the multi-PNA hybrids reflect the
strong A-form CD signature displayed in Fig. 22. Moreover, the structure of the
multi-PNA junctions showed little sensitivity to Mg2+ concentration in the range
examined (0.01mM – 2.00mM).
The CD spectra of the hybrid junctions indicate that the helicies of the
single-PNA hybrids more closely resemble those of J1 vs. the multi-PNA hybrids.
The CD wavelength scans suggest that secondary structure of the single-PNA
hybrids is largely composed of helices that possess A- and B-form
characteristics. Moreover, the CD spectra clearly show that ionic strength
strongly influences the secondary structure of the single-PNA hybrid junctions.
The CD spectra of the single-PNA hybrid junctions display a prominent increase
in B-form helices upon shifting the ionic strength of the buffer from 0.01mM to
2.00mM. Again, these spectra more closely resemble that of the DNA control,
J1. The CD spectra of the multi-PNA hybrid 4WJs deviate more significantly from
J1. The multi-PNA hybrids to have larger A-form helical character vs. single-PNA
hybrids and J1. Moreover, the secondary structure (A-form content) of the multiPNA hybrids are not sensitive to changes in ionic strength. One plausible
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explanation for the reduced level of ionic strength sensitivity may be the
increased hydrophobicity from the additional polyamide PNA peptide back-bone.
3.4 Thermal Melting Curves and Derivation of Thermodynamic Parameters
To examine the contribution of the PNA strands to thermal stability and
further explore the link between ionic strength and junction structure, the effects
of Mg2+ concentration, end blunting, and PNA strand content on the
conformational stability of hybrid 4WJs were examined. Thermal denaturation of
hybrid 4WJs was monitored by CD spectroscopy. Denaturation was examined by
monitoring the CD signal at the maxima near 280nm as each junction was
heated from 4°C to 100°C. Denaturation curves were generated by fitting the
data with a Boltzmann sigmoidal function, and are based on at least three
independent assays.
Denaturation curves are shown in Fig. 24A - G. The data has been
normalized from 0 - 1 to reflect the fraction of intact junction, with 1 being fully
intact and 0 being fully denatured. Junctions were examined at a concentration of
2.0μM.The data was fit with a Boltzmann sigmoidal function using GraphPad©.
Each line represents at least three independent melts. The denaturation curves
for J1 in low (0.01mM) and high (2.00mM) Mg2+ ion concentrations, shown in Fig
24A, have distinct S-shapes. These melting profiles are indicative of cooperative
two-state transitions from folded junction to unfolded strands.123 J1 denaturation
curves show estimated onsets of melting near 20°C, evidenced by a rapid
decrease in slope of the denaturation curve. The slopes of the J1 curves begin to
rapidly level off near 55°C, indicating J1 is almost fully denatured at this
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temperature. Full-length single-PNA junctions, 4WJ-PNA1 and 4WJ-PNA3 (Fig.
24B and D, respectively), show a much earlier onset of melting (<10°C) than the
other hybrid junctions (20°C -25°C) in both low (0.01mM) and high (2.00mM)
Mg2+ ion concentrations. 4WJ-PNA1 and 4WJ-PNA3 denaturation curves also
have more gradual slopes than those of the other junctions, giving them
comparatively larger melting ranges (≈10°C - 60°C). This may indicate more
gradual melting transitions or secondary pre-melting transitions for the full-length
single-PNA junctions.123 The blunt-ended single-PNA junctions, b4WJ-PNA1 and
b4WJ-PNA3 (Fig. 24C and E, respectively) appear to display clear cooperative
transitions between folded and unfolded states in low (0.01mM) and high
(2.00mM) Mg2+ ion concentrations. Both multi-PNA hybrids, 4WJ-PNA1,3 and
b4WJ-PNA1,3 (Fig. 24F and G, respectively) also seem to display cooperative
two-state transitions in low (0.01mM) and high (2.00mM) Mg2+ ion
concentrations. Both 4WJ-PNA1,3 and b4WJ-PNA1,3 showed particularly narrow
melting ranges (approximately 25°C to 45°C) and sharp transitions compared to
the other junctions.
The melt curves show that the blunt-ended single-PNA hybrids and multiPNA hybrids undergo sharper and more cooperative melting transitions
compared to the full-length single-PNA hybrids, suggesting an increase in
thermal stability. The earlier onset of melting and the more gradual slopes
suggest the full-length single-PNA hybrids exhibit some form of premelting
behavior, possibly due to the increased freedom of motion of the DNA
overhangs.
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Figure 24. Thermal melting curves of 4WJs in low versus high Mg2+
(A) J1, (B) 4WJ-PNA1, (C) b4WJ-PNA1, (D) 4WJ-PNA3, (E) b4WJ-PNA3, (F) 4WJ-PNA1,3, and (G) b4WJ-PNA1,3. High
Mg2+ (2.00mM) conditions are shown with open circles. Low Mg2+ (0.01mM) conditions are shown with solid circles. The
curves shown are Boltzmann sigmoid fits of the data. All junctions were examined at 2μM concentrations from 4°C to
100°C. The data shown are based on at least three independent assays.
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Melting curves were used to generate Tm values for J1 and the hybrid
junctions. Table 1 shows the Tm values for each junction in low (0.01mM) vs. high
(2.00mM) Mg2+ ion concentrations and ΔTm from low to high Mg2+ concentration.
The Tms for the single-PNA junctions and b4WJ-PNA1,3 are higher in the
presence of 2.00mM Mg2+ compared to 0.01mM Mg2+, suggesting that Mg2+has a
stabilizing effect on these junctions. For these junctions ΔTms from low to high
Mg2+ conditions range from 1.10°C (b4WJ-PNA3) to 4.28°C (4WJ-PNA3). The
multi-PNA junction 4WJ-PNA1,3 showed the opposite affect in the presence of
2.00mM Mg2+ showing a slight decrease in Tm (ΔTm = -0.55) compared to
0.01mM Mg2+. For the majority of the junctions examined, the ΔTms for low vs.
high Mg2+ suggest that hybrid 4WJs are stabilized by the presence of 2.00mM
Mg2+ ions. This stabilization effect may be attributed to an increase in the
stabilization of the solvation shell surrounding the junction lattice. 104,126
Table 1
4WJ Tms in low (0.01mM) and high (2.00mM) Mg2+
Junction

J1

4WJ-PNA1

b4WJ-PNA1

4WJ-PNA3

b4WJ-PNA3

4WJ-PNA1,3

b4WJ-PNA1,3

Tm (°C)
low Mg2+

39.47 ±1.03

32.53 ±1.34

32.83 ±0.86

31.47 ±2.25

40.08 ±0.87

35.60 ±0.78

30.94 ±0.63

Tm (°C)
high Mg2+

40.04 ±1.04

34.00 ±0.87

35.55 ±1.05

35.75 ±1.83

41.18 ±1.21

35.05 ±0.40

32.95 ±0.75

ΔTm (°C)
high - low

0.57

1.47

2.72

4.28

1.10

-0.55

2.01

ΔTm values show differences in Tms of each junction in low (0.01mM) vs. high (2mM) Mg2+
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The ΔTm values for each hybrid vs. J1 in low (0.01mM) and high (2.00mM)
Mg2+ ion concentrations are listed in Table 2. The ΔTm values show the majority
of the hybrid junctions to be slightly less thermally stable than J1 at both high and
low Mg2+ concentrations. Only b4WJ-PNA3 showed an increase in Tm versus J1
(ΔTm = 1.14°C in 0.01mM Mg2+ ion concentration and ΔTm = 1.14°C in 2.00mM
Mg2+ ion concentration). The ΔTm value for each hybrid vs. J1 in 0.01mM Mg2+
range from - 8.53°C (b4WJ-PNA1,3) to 0.61°C (b4WJ-PNA3). Upon shifting to
2mM Mg2+, the ΔTm values of the hybrids vs. J1 range from - 7.09°C (b4WJPNA1,3) to 1.14°C (b4WJ-PNA3). This further illustrates the Mg2+ sensitivity of
hybrid 4WJs. The increase in Tm of b4WJ-PNA3 compared to J1 indicates that
addition of PNA strands to the junction lattice is a viable method for increasing
the thermal stability of 4WJs.
Table 2
Hybrid junctions vs. J1 in low (0.01mM) and high (2.00mM) Mg2+
Junction

J1

4WJ-PNA1

b4WJ-PNA1

4WJ-PNA3

b4WJ-PNA3

4WJ-PNA1,3

b4WJ-PNA1,3

Tm (°C)
low Mg2+

39.47 ±1.03

32.53 ±1.34

32.83 ±0.86

31.47 ±2.25

40.08 ±0.87

35.60 ±0.78

30.94 ±0.63

-8.04

0.61

-3.87

-8.53

35.55 ±1.05

35.75 ±1.83

41.18 ±1.21

35.05 ±0.40

32.95 ±0.75

-4.49

-4.29

1.14

ΔTm (°C)
hybrid - J1

-

Tm (°C)
high Mg2+

40.04 ±1.04

ΔTm (°C)
hybrid - J1

-

-6.94

34.00 ±0.87

-6.04

-6.64

ΔTm values show differences in Tms of each hybrid vs. J1
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-4.99

-7.09

Table 3
Full-length junctions vs. blunt-ended junctions in low (0.01mM) and high
(2.00mM) Mg2+
Junction

4WJ-PNA1

b4WJ-PNA1

4WJ-PNA3

b4WJ-PNA3

4WJ-PNA1,3

b4WJ-PNA1,3

Tm (°C)
low Mg2+

32.53 ±1.34

32.83 ±0.86

31.47 ±2.25

40.08 ±0.87

35.60 ±0.78

30.94 ±0.63

ΔTm (°C)
blunt-full

-

-

8.61

-

-4.66

Tm (°C)
high Mg2+

34.00 ±0.87

35.75 ±1.83

41.18 ±1.21

35.05 ±0.40

32.95 ±0.75

ΔTm (°C)
blunt - full

-

-

5.43

-

-2.10

0.30

35.55 ±1.05

1.55

ΔTm values show differences in Tms of each full-length junction containing overhangs vs. blunt-ended junctions.

The freedom of motion of the DNA overhangs present in full-length
junctions 4WJ-PNA1, 4WJ-PNA3, and 4WJ-PNA1,3 may result in structural
instability of these hybrid junctions. To evaluate the effects of removing DNA
overhangs, Tm values of full-length junctions were compared to blunt-ended
junctions. The resulting ΔTms are listed in Table 3. Truncating the overhangs
increased the Tms of the single-PNA hybrids in both low (0.01mM) and high
(2.00mM) Mg2+. The junction b4WJ-PNA3 showed the highest ΔTms in both low
(ΔTm = 8.61°C) and high Mg2+ (ΔTm = 5.43°C). The results for the single-PNA
hybrids suggest that removal of DNA overhangs produces a stabilizing effect on
these hybrid junctions. However, a reduction in Tm was observed between the
full-length multi-PNA hybrid and its blunt-ended counter part. For the multi-PNA
hybrids, the thermal unfolding data shows the Tm value for b4WJ-PNA1,3 is 52

4.66°C lower than 4WJ-PNA1,3 in low Mg2+ and -2.10°C lower in high Mg2+. The
reduction in Tm shown for 4WJ-PNA1,3 vs. b4WJ-PNA1,3 may be a result of
different forces stabilizing the tertiary structure (i.e. stacked-X conformation). The
increased hydrophobicity imparted by the PNA strands may lead to a stabilization
from the hydrophobic effect. The DNA overhangs of 4WJ-PNA1,3 may act as a
negatively charged shell around a more hydrophobic core, ordering the solvent
cage around 4WJ-PNA1,3 resulting in an increased Tm compared to b4WJ-PNA1,3.
In order to further examine the temperature- dependent melting behavior
of 4WJs, the melting curves from Fig. 24 were analyzed for van’t Hoff transition
enthalpies (ΔHVH). The values of ΔHVH are a function of the equilibrium constant
(Keq) and calculated from the rate of change in fraction of DNA/PNA strands in
junction form at the Tms. The melting curves were normalized to produce upper
and lower baselines of 1 and 0, respectively. The Y-axis then reflects the fraction
of DNA/PNA strands in junction form as α. Plots of δα /δT vs. T (Fig. 25) were
produced from the first derivatives of the Boltzmann sigmoidal functions used to
fit the normalized melting data. The smooth S-shaped melt curves (Fig. 24)
displayed by most of the hybrid 4WJs indicate a two-state transition between
folded and unfolded states. However, the unfolding of the full-length single-PNA
constructs was slow, possibly indicating a gradual transition. The presence of
multiple peaks or shoulders in the first derivatives of the melting curves would
indicate a non-cooperative gradual transition. Fig. 25 shows the first derivatives
of the melting curves have only single peaks giving a clear indication that all
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hybrid 4WJs undergo a cooperative two state transition upon
melting.24,26,112,113,123
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Figure 25. First derivatives of 4WJ melting curves
The curves show the first derivatives of the Boltzmann sigmoidal functions used to fit the thermal denaturation data. The
change in fraction of free strands as a function of time (δα /δT) is shown on the Y-axis. Minima represent junction Tms.
Each junction is shown in low vs. high Mg2+. High Mg2+ (2mM) conditions are shown with a solid line. Low Mg 2+ (100μM)
conditions are shown with a dashed line.

55

Calculation of ΔHVH from the first derivatives of the melting curves was
done using the three previously discussed methods. Eq. 1, derived from the
general form of van’t Hoff’s equation, is listed as method 1. The Y values at the
maxima of the differentiated melting curves are δα /δTm. Eq. 2 was used to
calculate ΔHVH from the full width of the differentiated melting curve at half height,
and is listed as method 2. Values for T1 (lower value) and T2 (upper value) were
taken at (δα /δT)0.5 from the differentiated melting curves. Eq. 3 was used to
calculate ΔHVH from the half width of the differentiated melting curve at half
height, and is listed as method 3. The association reaction constants for
tetramolecular nucleic acid interactions used for the calculation of ΔHVH at the full
(B) and half-widths (B’) were reported in previous work by Marky and
Breslauer.123 In this case a molecularity of n=4 yields values of 15.40 for B and
5.63 for B’.
Comparisons of the ΔHVH values for J1 vs. each hybrid junction are shown
in Table 4 for both low and high Mg2+ ion concentrations. Table 4 shows that, at a
2.00mM Mg2+ ion concentration, ΔHVH values of 4WJ-PNA1 and 4WJ-PNA3,
decrease by approximately 1.4 to 5.4 kcal/mol compared to J1. These results are
in line with the Tm results, suggesting that 4WJ-PNA1 and 4WJ-PNA3 are less
stable than J1 at a 2.00mM Mg2+ ion concentration. At a 0.01mM Mg2+ ion
concentration ΔHVH values for 4WJ-PNA1 and 4WJ-PNA3 decrease by 0.5 and
14.8 kcal/mol, respectively, again suggesting a decrease in stability compared to
J1 in line with the Tm results. At a 0.01 mM Mg2+ ion concentration b4WJ-PNA3
appears slightly more stable than J1, showing a 3.3 kcal/mol increase in ΔHVH
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compared to J1. However, at a 2.00 mM Mg2+ ion concentration b4WJ-PNA3
showed a 4.7 kcal/mol decrease in ΔHVH compared to J1. This is in contrast to
the Tm comparison between b4WJ-PNA3 and J1, which showed b4WJ-PNA3 to
have a higher Tm than J1 at a 2.00mM Mg2+ ion concentration and a lower Tm
than J1 at 0.01mM Mg2+ ion concentration.
Table 4
ΔHVH of Hybrid junctions vs. J1 in low (0.01mM) and high (2.00mM) Mg 2+
Junction

J1

ΔHVH
(kcal/mol)
low Mg2+
ΔHVH
(kcal/mol)
hybrid - J1
ΔHVH
(kcal/mol)
high Mg2+
ΔHVH
(kcal/mol)
hybrid - J1

42.5 ±6.3

-

46.6 ±6.7

-

4WJ-PNA1
42.0 ±5.7

-0.5

41.2 ±5.6

-5.4

b4WJ-PNA1

4WJ-PNA3

b4WJ-PNA3

57.7 ±8.6

27.7 ±3.3

45.8 ±8.6

15.2

64.3 ±9.3

-14.8

32.3 ±4.7

17.7

-1.43

3.3

41.9 ±6.3

-4.7

4WJ-PNA1,3
61.7 ±9.4

19.2

72.2 ±11.5

25.6

b4WJ-PNA1,3
53.3 ±7.5

10.8

61.9 ±9.3

15.3

Values are shown for each junction at low (0.01mM) and high (2.00mM) Mg2+ ion concentrations.

The reduction in ΔHVH shown for the full-length single-PNA junctions 4WJPNA1 and 4WJ-PNA3 compared to J1 may be attributed to destabilizing effects
from the loss of four DNA base pairs and the increased freedom of motion of the
unpaired DNA overhangs. The PNA3 constructs 4WJ-PNA3 and b4WJ-PNA3 may
have lower ΔHVH values than J1 due not only to loss of four base pairs, but also
to the presence of the three AT pairs at the ends of junction arm III. The AT pairs
at the ends of 4WJ-PNA3 and b4WJ-PNA3 are less stable than the GC pairs at
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the ends of J1 and may lead to premature onset of melting and lower ΔHVH
values.
Table 4 shows that in both low (0.01mM) and high (2.00mM) Mg2+ ion
concentrations the ΔHVH values of b4WJ-PNA1, 4WJ-PNA1,3, and b4WJ-PNA1,3
increase by 10 - 25 kcal/mol compared to J1. This is in contrast to a decrease of
approximately 4°C - 9°C in the Tms of b4WJ-PNA1, 4WJ-PNA1,3, and b4WJPNA1,3 compared to J1. The decrease in Tm values coupled with an increase in
ΔHVH values compared to J1 suggests that the b4WJ-PNA1 and the multi-PNA
hybrids may be more stable than J1 in the lower range of temperatures examined
(4°C - 25°C). This is evidenced by the relatively flat upper portion of the melt
curves between 4°C and 25°C, and the sharp drop in CD signal near the T ms for
b4WJ-PNA1, 4WJ-PNA1,3, and b4WJ-PNA1,3 (Fig. 24C, F, and G, respectively).
The melt profile of J1 (Fig. 24A) displays an initial drop in CD signal at a slighltly
lower temperature (20°C) in comparison to b4WJ-PNA1, 4WJ-PNA1,3, and
b4WJ-PNA1,3 (25°C), and displays a much more gradual loss of signal.
More favorable base-stacking interactions from the reduced charge
repulsion imparted by the PNA1 strand coupled with the stabilizing effect of
removing DNA overhangs may lead to a higher ΔHVH for b4WJ-PNA1 compared
to J1. The increase values of ΔHVH shown for the multi-PNA hybrids compared to
J1 may again be due to more favorable base-stacking interactions. The
increased flexibility of PNA and the lack of charge repulsion between the DNA
and PNA strands may allow the multi-PNA hybrids to maximize base-stacking
interactions of all four arms, producing a stabilizing effect on the helical structure
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of these junctions at temperatures below 25°C. Alternatively, the multi-PNA
hybrids may possess a more stable stacked-X structure than the other junctions
at temperatures below 25°C that must first unfold before denaturation can occur.
Above 25°C the stabilizing effect of favorable base-stacking interactions or
stacked-X structure may be overcome by the destabilizing effects of loss of eight
base pairs compared to J1 and a more disordered solvent cage from the
increased hydrophobicity imparted by the PNA strands. These combined effects
may lead to the higher ΔHVH and lower Tms observed for 4WJ-PNA1,3 and b4WJPNA1,3 compared to J1.
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CHAPTER IV - DISCUSSION AND CONCLUSION
4.1 Discussion
The goal of this study was to examine hybrid PNA-DNA 4WJs as possible
therapeutics to target HMGB1. EMSAs, used to probe binding interactions of
HMGB1b with hybrid 4WJs, suggest that HMGB1b recognizes single-PNA hybrid
4WJs, b4WJ-PNA1 and b4WJ-PNA3, with similar affinity to the DNA control, J1
(Fig. 21B and C) supporting the hypothesis that the DNA-binding cytokine,
HMGB1, recognizes unnatural nucleic acid substrates. CD, used to examine
structural differences between hybrid PNA-DNA junctions and pure DNA
junctions, showed that single-PNA hybrid junctions have a more B-form helical
character than the multi-PNA hybrids. Together, the EMSA and CD structural
analysis results suggest that the helical structure of the hybrid 4WJs may be a
key factor influencing HMGB1b binding affinity. Thermal melting behavior was
examined via CD to guage the relative stabilities of hybrid PNA-DNA junctions
compared to pure DNA junctions. The single-PNA hybrid b4WJ-PNA3 showed
increased Tm compared to J1. The EMSA and thermal analysis results suggest
that the single-PNA hybrid b4WJ-PNA3 poseses a similar HMGB1b binding
affinity and enhanced thermal stability compared to its DNA parent structure J1.
This suggests that b4WJ-PNA3 may be a suitable therapeutic ligand for HMGB1.
There are several plausible explanations to explain why HMGB1b
recognizes certain hybrid 4WJs more readily. Two of the main possibilities are
linked to: i) the rotation angle between adjacent helices in the junction lattice
(Jtwist) and ii) topology (dimensions) of the minor groove of each 4WJ. Previous
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studies utilizing X-ray crystallography, electrophoresis, FRET and atomic force
microscopy have shown that the rotation angle (Jtwist) between the two adjacent
helices of a J1 in the stacked-X form is between 56.5° - 60°.77,96,110,112,113,127
These Jtwist dimensions presumably facilitate protein recognition by placing the
junction branch point in a favorable conformation for HMGB1b binding. 77,96 We
suspect that the single-PNA hybrids have a similar Jtwist value to J1 that
promotes protein binding. The multi-PNA, however, possess PNA strands that
represent ~50% of the junction lattice. In this case, the flexible PNA backbones
of the multi-PNA hybrids enable the junction lattice to assume Jtwist values that
are either > or < 56.5° - 60°. As a result, the multi-PNA junctions may adopt
unfavorable conformations that destabilize HMGB1b binding interactions. As a
result, discreet 4:1 complexes do not form. The schematic below (Fig. 26) shows
a model of the potential binding interactions of HMGB1b with single-PNA (Fig.
26A) and multi-PNA hybrids (Fig. 26B). I suspect that the Jtwist angles between
the junction arms of the single-PNA hybrids (Fig. 26A) more closely match the
60° angles of the DNA control, J1 than do the multi-PNA hybrids. The Jtwist
angles of the multi-PNA hybrids (Fig. 26B) may deviate to produce more acute or
obtuse angles that are unfavorable for HMGB1b binding. The reduction in binding
affinity of HMGB1b toward multi-PNA hybrids seen in the EMSAs (Fig. 21F and
G) may be due to reduced access to the 4WJ binding sites or additional energy
differences between unbound and bound 4WJ conformations as a result of
unfavorable Jtwist angles as illustrated in Fig 26B. Another possible reason for
the reduced affinity observed between HMGB1b and the multi-PNA hybrids may
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be the lack of electrostatic interactions between HMGB1b and both PNA
backbones of these junctions. Additionally, electrostatic interactions between
positively charged residues along the binding face of HMGB1b and junctions are
lost from replacement of two sugar/phosphate backbones with uncharged PNAs
for the multi-PNA 4WJs vs. one for the single-PNA junctions. This 50% reduction
in backbone charge of the multi-PNA junctions is a likely contributor to the
reduced affinity shown for HMGB1b in the EMSAs.

Figure 26. Schematic of the effects of changing Jtwist angle on HMGB1 binding.
With respect to changes in the topology of 4WJs, it is well known that the
minor groove of A-DNA is broader than B-form DNA.112,126,128 HMGB1b is binds
within the minor groove of B-DNA. Presumably, the narrow minor groove of BDNA promotes enhanced binding contacts with HMGB1b. Conversely, the hybrid
4WJs with large fraction of A-form helices (i.e. the multi-PNA junctions) possess
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broader minor groove dimensions that may reduce contacts with HMGB1b. NMR
studies of hybrid PNA-DNA duplexes by Eriksson et al. showed these substrates
to possess characteristics of both A- and B-form DNA.105 In this study, the multiPNA hybrid junctions have an approximately 9-fold larger A-form signal at 205
nM compared to J1. Although CD does not provide high-resolution data, one
may surmise that the minor groove dimensions of the helices measured via CD
have similarities to the known 3-D structures of B- and A-form DNA duplexes. If
this is the case, the B-form helices found in J1 have a narrow, shallow minor
groove topology, while the helices of the hybrid junctions have broader, shallower
minor grooves intermediate between the topology of A- and B-DNA. Fig. 27
displays a model of minor groove of B-, B/A, and A-DNA helices. It is clear that
B-DNA helices (left panel) have narrow minor groove that may enable proteins
(presumably HMGB1b) to fit firmly into the groove. The intermediate structure
B/A possesses a broader minor groove. I hypothesize that single-PNA structures
have a minor groove topology that is more similar to the intermediate B/A model.
Hence, HMGB1b fits firmly into this minor groove and forms discreet 4:1
complexes similar to J1. This viewpoint is strengthened by NMR data of PNADNA duplexes; these hybrid PNA-DNA duplexes possess structural features
intermediate between B- and A-DNA (as shown in Fig. 13). With respect to the
multi-PNA hybrids, the CD data shows that these constructs are composed
largely of A-DNA helices. Hence, we hypothesize the multi-PNA 4WJs have a
broader minor groove that is more similar to the A-DNA structure shown in Fig.
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27 (right panel). If this is the case, HMB1b does not fit firmly into the minor
groove.

Figure 27. Space filling 3D models of B-DNA, A-B intermediate DNA, and ADNA.
With respect to the thermostability of hybrid 4WJs vs. J1, thermal melting
curves (Fig. 24) show that high Mg2+ enhances the stability of five of the six
hybrid junctions examined (Table 1). The single-PNA hybrids showed a
noticeable correlation between ionic strength of the solvent (H2O), B-form helical
content, and Tm. The single-PNA constructs favor B-form helices and possess
enhanced Tm values in high Mg2+ compared to the multi-PNA junctions. This
correlation is most evident for b4WJ-PNA3. In the presence of high Mg2+ ion
concentration, b4WJ-PNA3 possesses higher B-form structure (AFB) and Tm
values than the DNA control, J1. This effect may again be due to an increase in
solvent accessibility of Mg2+ for the major grooves of the single-PNA junctions
reducing charge repulsion between DNA strands and the forming of a more
organized solvent cage around the junctions.126,129,130 Support for this hypothesis
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is provided by molecular dynamics (MD) simulations data that show B-DNA
helices are preferred in high activity solvent(s) due to favorable solvation free
energy values.126,130 The corresponding solvation free energy values are
considerably smaller for A-DNA helices.126 The addition of uncharged PNA
strands to the 4WJs may provide a more hydrophobic environment near their
complementary DNA strands, reducing the solvation free energies. This results in
hybrid PNA-DNA 4WJs having more A-form like helices compared to J1, as
evidenced by the CD results (Fig. 22). In high ionic strength environments (i.e.
2mM Mg2+), counter ion interactions with the DNA phosphate backbone may be
strengthened as a result of an increased extent of counter ion condensation in
the more hydrophobic environment produced by the PNA strands. This is
evidenced by the increase in Tm for most junctions in 2mM Mg2+ ion
concentrations (Table 1).
4.2 Conclusion
Both single-PNA junctions b4WJ-PNA1 and b4WJ-PNA3 bind HMGB1b
with similar affinity to pure DNA 4WJs. Replacement of a single J1 strand with a
PNA did not seem to perturb HMGB1 binding affinity. While the single PNA
constructs b4WJ-PNA1 and b4WJ-PNA3 were shown to bind HMGB1 with similar
affinities to that of the parent DNA 4WJ, J1, the multi-PNA junctions showed a
marked decrease in binding affinity and did not form stable complexes. This may
be a result of the increased freedom of movement imparted by lack of
electrostatic repulsion between the DNA strands and the uncharged PNA
backbone. HMGB1b presumably binds each junction across the branch point.
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The increased freedom of motion may cause a deviation in the canonical Jtwist
angle at the branch point and/or a deviation in helical structure. This deviation in
Jtwist angle may limit access of HMGB1b to the junction branch point or
decreasing the stability of protein/junction complexes formed between HMGB1b
and the multi-PNA hybrids.
The strand replacement and end-blunting strategy showed success in
increasing the thermal stability of b4WJ-PNA3 vs. J1 under conditions used to
mimic average ECM Mg2+ ion concentration (i.e. 2.00mM). At a Mg2+ ion
concentration of 2.00mM, junction b4WJ-PNA3 showed an increase in Tm vs. J1
of 1.14°C and a large increase in Tm vs. 4WJ-PNA3 of 8.61°C. At a 2.00mM
Mg2+ ion concentration, single-PNA hybrid junction b4WJ-PNA3, with a Tm of
41.18°C, was shown to remain stable well above normal body temperature of
37°C and slightly above high fever temperatures of 40°C.
The results of this study suggest that hybrid PNA-DNA 4WJs warrant
further investigation as possible therapeutic agents against unwanted HMGB1
cytokine activity. Junction b4WJ-PNA3 was shown capable of binding HMGB1b
with an affinity similar to that of its parent DNA junction and has a Tm well above
normal body temperature. This study suggests that b4WJ-PNA3 may successfully
target HMGB1 in vivo and that b4WJ-PNA3 may remain thermally stable in the
body even at elevated temperatures often associated with inflammation.
Future plans are to examine the consequences of replacing strands 102
and 104. In the stacked-X conformation strands 101 and 103 represent the
continuous strands. Replacing one or both of the crossover strands may have
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much different effects on local and global conformation as well as junction
stability. Additionally, studies are planned to examine the serum stability and
nuclease resistance of hybrid 4WJs. The formulation of junctions containing
chimeric strands composed of both PNA and DNA is being examined as a
possible strategy for improving junction stability while maintaining substrate
viability.
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CHAPTER V – A POSSIBLE LINK BETWEEN AMINO ACID SELECTIVITY OF
AMINOACYL-TRNA SYNTHETASES AND GENETIC CODE DEVELOPMENT
5.1 Synopsis and Hypotheses
The genetic code is a cornerstone of molecular and cell biology that has
fascinated scientists for decades. Despite having a clear grasp of the basic
features of the code, several key questions about its origin remain unsolved.
Among these questions, the chronology of amino acid (AA) emergence and
codification are largely unresolved. The objective of Chapters V through VIII is to
use experimental data to provide evidence to support current genetic code origin
theories. Aminoacyl-tRNA synthetases (aaRSs), the enzymes responsible for
production of aminoacyl-tRNAs (aa-tRNAs) in the first step of protein translation,
are used to perform a selection survey of the 20 natural AAs. Several previous
studies have suggested that aaRSs are among the oldest families of proteins. 131134

It has also been suggested that ancestral aaRSs arose during a period of an

incomplete genetic code (i.e. fewer than 20 AAs) and initially had little AA
specificity.131,134 These suppositions imply that ancestral aaRSs initially
developed specificity toward an incomplete or primitive set of AAs. I hypothesize
that extant aaRSs may retain a selection preference for the substrates of
their ancestors and that the pool of AAs selected by multiple aaRSs
represent an early set AAs used in primitive translation.
In this study, a radiometric assay is used to probe for an AA activation
imprint (i.e. a selection preference) that is inherent to certain AAs. Using
experimental techniques focused on elucidating connections between AAs and
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extant aaRSs may provide novel insight into the process of genetic code
development. By examining AA selection in the form of misactivation profiles we
will provide empirical evidence to support a chronology of AA codification. Fig. 28
shows the two-step synthesis of aa-tRNAs. In Fig. 28 step 1 an AA and a
molecule of ATP react to form an aminoacyl-adenylate (AA-AMP) with release of
a diphosphate (PPi). In Fig 28 step 2 the AA moiety of the AA-AMP is transferred
to a tRNA to form an aa-tRNA. This study focuses solely upon the activation
reaction shown in step 1 of Fig. 28 and examines the AA discriminating ability of
each aaRS. The omission of tRNAs provided an opportunity to examine if certain
AAs are structurally and/or chemically predisposed to reacting with aaRSs.
Moreover, these investigations revealed potential biosynthetic imprints between
AAs and aaRSs in the form of selection preferences, that exist in the absence of
tRNAs, and suggest a relationship between aaRS specificity and AA biosynthesis
and codification. These findings were compared to genetic code origin studies
examining AA abundance in early Earth simulations135-138 and meteorites139-142,
physiochemical properties of AAs143-145, and AA biosynthetic pathways146-149.

Figure 28. A schematic of the aaRS catalyzed aminoacylation reaction
Step 1 shows the activation of an AA to produce AA-AMP. Step 2 shows the charging of the AA moiety of the AA-AMP to
a tRNA to produce an aa-tRNA
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5.2 Code Origin Theories
5.2.1 Connections between AA Emergence and the Early Earth
The original simulated primitive earth experiments performed by Miller and
Urey reportedly produced a variety of organic compounds including AAs such as:
Ala, Gly, Val, Asp, and Glu.136 The Miller-Urey experiments have been rigorously
scrutinized and modified to yield similar results under a wide range of possible
conditions.135,137,138,150-152 The original experiments used electric discharges on a
mixture of hydrogen (H2), H2O, methane (CH4), and ammonia (NH3) to produce
organic compounds.136,150 Subsequent experiments incorporated other gases
such as carbon dioxide (CO2), nitrogen (N2)137,150, and hydrogen sulfide (H2S)151
and an aspirator to inject steam138. These simulated primitive earth experiments
have produced a variety of organic compounds, including simple AAs. The
combined results of four such analyses are shown in Table 5.135,137,138,150
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Table 5
Prebiotic AAs produced in early Earth simulations
Amino Acid identified in Early Earth
Simulations
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
b
a
a
a
c
a

Glycine
Alanine
α-Amino-n-btyric acid
α-Hydroxy-γ-amino butyric acid
Norvaline
Sarcosine
Aspartic acid
α,γ-diaminobutyric acid
α-Aminoisobutyric acid
N-ethyl glycine
Valine
β-Alanine
N-methyl alanine
Leucine
Glutamic acid
α,β-diaminopropionic acid
Alloisoleucine
Serine
Isoleucine
Norleucine
Isoserine
α-Methyl-α-amino-n-butyric acid (isovaline)
N-methyl-β-alanine
γ-Aminobutyric acid
Homocysteine
N-propyl glycine

Relative Abundance
(Gly = 100)

Amino Acid identified in Early Earth
Simulations

100
180
61
17
14
12.5
7.7
7.6
7
6.8
4.4
4.3
3.4
2.6
1.7
1.5
1.2
1.1
1.1
1-4
2
1
1.0
0.5
0.5
0.5

a
a
a
b
c
a
a
a
a
a
c
a
b
a
d
a
a
a
b
d
b
b
b
b
d
d

N-isopropyl glycine
N-ethyl-β-alanine
Isoserine
Isovaline
α-Amino-n-heptanoic acid
Proline
Threonine
Allothreonine
β-Amino-n-butyric acid
β-Aminoisobutyric acid
Methionine
N-ethyl alanine
β-Hydroxy aspartic acid
Pipecolic acid
Ethionine
Ornithine
Lysine
t-Leucine
2-Methyl serine
Methionine sulfoxide
α-amino adipic acid
Homoserine
2-methyl glutamic acid
Phenylalanine
Methionine sulfone
S-Methylcysteine

Relative Abundance
(Gly = 100)
0.5
0.5
1.2
0.99
0.3
0.3
0.2
0.2
0.1
0.1
0.1
<0.05
0.013
0.01
0.01
<0.01
<0.01
<0.005
0.0016
<0.001
0.00038
0.00034
0.00024
0.0002
<0.0002
<0.0002

AAs are listed according to the highest relative abundance compared to Gly (Gly = 100)135,137,138,150.

Many of the same organic compounds produced in early Earth simulations
have also been found in studies of carbonaceous meteorite compositions.
Studies examining the compositions of carbonaceous meteorites have shown
them to be rich sources of organic compounds, including a large number of AAs.
The Murchison139,141, Orgueil140, and Murray142 are well studied carbonaceous
meteorites shown to contain many of the same canonical proteinacious AAs seen
in the early Earth simulations including Gly, Ala, Val, Pro, Ser, Asp, and Glu. A
list of AAs found in examinations of these meteorites is shown in Table 6. 139-142
Early Earth simulations and meteorite examinations provide evidence for the
existence of prebiotic AA sources from which a primitive translation system could
be built upon. The identification of proteinacious AAs in early Earth simulations
and meteorite examinations provides evidence for the early availability of these
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AAs, but does not identify them as early coded AAs. However, studies examining
genetic code origins often point to many of the AAs identified in these early Earth
simulations and meteorite examinations as early coded AAs.147-149,153-162
Table 6
AAs identified in carbonaceous meteorites
Amino Acid identified in Carbonaceous Meteorites
1,2-methyl aspartic acid
2-Amino-2-ethyl-3-methylbutanoic acid
2-amino-2-ethylbutyric acid
2-amino-2-ethylpentanoic acid
2-amino-2-methylhexanoic acid
2-amino-2,3-dimethylbutyric acid
2-amino-2,3-dimethylpentanoic acid
2-amino-2,3,3-trimethylbutanoic acid
2-amino-2,4-dimethylpentanoic acid
2-amino-3-ethylpentanoic acid
2-amino-3-methylhexanoic acid
2-amino-3,3-dimethylpentanoic acid
2-amino-3,4-dimethylpentanoic acid
2-amino-4-methylhexanoic acid
2-amino-4,4-dimethylpentanoic acid
2-amino-5-methylhexanoic acid
2-aminoheptanoic acid
2-methyl glutamic acid
2-methylnorvaline

a,b

b
a,b

a,b
b

3-amino-2-ethylpropanoic acid
3-amino-2-methylbutanoic acid
3-amino-2,2-dimethylpropanoic acid
3-aminopentanoic acid
3,3 methyl aspartic acid
4-amino-2-methylbutanoic acid
4-amino-3-methylbutanoic acid
4-aminopentanoic acid
Alanine
allo-2-amino-3,4-dimethylpentanoic acid
allo-3-amino-2-methylbutanoic acid
allo-3-methyl aspartic acid
allo-Isoleucine
Aspartic acid
Cycloleucine
Glutamic acid
Glycine
Isoleucine
Isovaline

b

a,b
a
b
b
a,b
a
a,b
a
a
a

Leucine
Norleucine
Norvaline
Proline
Pseudoleucine
Sacrosine
Serine
Threonine
Valine
α-Amino-n-butyric acid
α-Aminoisobutyric acid
β-Alanine
β-Amino-n-butyric acid
β-Aminobutyric acid
β-Aminoisobutyric acid
γ-Aminobutyric acid
δ-aminovaleric acid
ε-aminocaporic acid

All studies employed mass spec coupled GC to examine material from the inner portion of fragments from each meteorite.
Amino acids denoted with an a or b were also found in the Orguil and Murray meteorites, respectively 139-142.

5.2.2 Connections between AA Emergence and the Coevolution Theory (CET)
There are a many theories to explain the establishment of the genetic
code, some of the most notable are: the coevolution theory (CET)147-149,153,155,
the stereochemical hypothesis157,163,164 and error minimization hypothesis
158,159,165.

These theories are not mutually exclusive and each supposition likely

played a role in the formation of the genetic code.149,153,154
The CET predicts that the structure of the genetic code is an imprint of
these biosynthetic pathways and the precursor product relationships between
AAs.147 The CET assumes that the genetic code was initially comprised of a
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smaller set of precursor AAs (phase 1 AAs) encoded by proto-tRNAs. As
primitive biosynthetic pathways became more complex, the evolution of
precursor AAs to product AAs (phase 2 AAs) was facilitated by these prototRNAs.147-149,153 Genetic code structure then becomes a consequence of
precursor AAs conceding codons to product AAs. Support for this theory lays in
the extant precursor/product relationships of AAs and the similarity of their
codons.147 Figure Fig. 29 shows a proposed evolutionary map of the genetic
code development with arrows denoting extant AA precursor/product
relationships (single-headed arrows) and interconversion relationships (doubleheaded arrows).147 Codons shown in solid boxes correspond to the extant use in
the genetic code. Codons in the dotted boxes for Glu and Asp were presumably
conceded to product Gln and Asn in the later stages of codon assignment. The
codons of each precursor/product pair are contiguous, differing by only a single
nucleotide. This mechanism of codon assignment proposed in the CET assumes
that primordial AAs each occupied continuous regions of the genetic code and
that codons from this region were conceded to product AAs consistent with the
observed contiguity of precursor AA and product AA codons.147-149 From the
biosynthetic and codon relationships shown in Fig. 29, a set of central AAs
emerges from which all others seemingly evolved and allows the generation of a
basic chronology of AA codification. This set of seven precursor AAs comprised
of Glu, Asp, Ala, Ser, Gly, Phe, and Val is presumed by the CET to be the
earliest set of coded AAs. These AAs are found in relatively high abundance in
early Earth and meteorite studies giving support to their “early” status.
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Figure 29. Codon evolution map proposed in the coevolutionary theory.
From “A co-evolutiontheory of the genetic code,” by Wong 1975, Proc. Nat. Acad. Sci. 72, 1909-1912. Copyright 1975 by
Proc. Nat. Acad. Sci. Reprinted with permission of the author.147

5.2.3 Connections between AA Emergence and AA Biosynthetic Pathways
The investigation of AA biosynthetic pathways has been used to make
inferences of the relative ages of AAs and aaRSs. It has been proposed that
class II aaRSs and their respective AAs are, as a group, more ancient than class
I aaRSs and AAs.146 This proposal was based on the AA precursor/product
relationships and distances from the glycolysis pathway, pentose pathway, and
citric acid cycle. Fig. 30 shows a schematic of the AA biosynthetic pathways
showing the AAs and their respective codons. AAs specific to class I aaRSs are
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shown in white and AAs specific to class II aaRSs are shown in grey. While it is
true that a higher number of class II specific AAs occupy interior nodes of the
diagram, several of the class I AAs occupy positions very close to the glycolysis
pathway and citric acid cycle. Also, the class I AA Glu is an important precursor
in the biosynthesis of Pro, a class II AA. Though the primary goal of this previous
AA biosynthetic pathway study was to examine the relative ages of the aaRS
classes, it also provided insight into the chronology of AAs. Fig. 30 illustrates the
extant precursor/product relationships between AAs and shows their proximity to
glycolysis, the pentose phosphate pathway, and the citric acid cycle. The extant
machinery involved in these biosynthetic pathways is undoubtedly quite different
from that found in early metabolisms. However, the precursor/product
relationships of the AAs may be an artifact of an early metabolic system. The
precursor product relationships shown in Fig. 30 were used to produce a three
stage chronology of AA codification with Ala, Val, Gly, Ser, Asp, and Glu as more
ancient; Asn, Thr, Gln, and Pro at an intermediary stage; and Leu, Phe, Tyr, Trp,
His, Cys, Met, Lys, Ile, and Arg as more recent.146
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Figure 30. AA biosynthetic pathways
From “Amino acid biogenisis, evolution of the genetic code and aminoacyl-tRNA synthetases,” by Klipcan et. al.2004. J.
Theor. Biol. 228, 389-396. Copyright 2004 by Elsevier. Reprinted with permission of the author.146

5.2.4 Connections between AA Emergence and AA Physiochemical Properties
Studies examining physiochemical properties of AAs have revealed AA
stability, polarity, and complexity as factors that correlate strongly with previously
discussed code origin theories.143-145 One study compared the free energies of
the 20 natural AAs to sets of corresponding isomers.166 Comparing the free
energies of formation of the 20 natural AAs to one another showed a set of
particularly stable AAs (Gly, Ala, Ser, Pro, Val, Thr, Asp, and Glu) that largely
correspond to the set considered ancient by early Earth simulations, meteorite
studies, and the CET. Larger AAs His, Phe, Arg, Tyr, and Trp were shown to be
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the least stable in terms of free energy of formation.166 Another study examined a
set of 40 criteria and hypotheses associated with genetic code development. 144
This study identified thermal stability of codon-anticodon interactions, codon
complementarities, abiotic origin, and AA size/complexity as major factors that
correlate with AA age. This study was used to produce a chronological ranking of
AAs from earliest to late as follows Gly/Ala, Val/Asp, Pro, Ser, Glu/Leu, Thr, Arg,
Asn, Lys, Gln, Ile, Cys, His, Phe, Met, Tyr, Trp.144
All of the theories discussed here assume a gradual progression of
genetic code development. During this period, codons would not have been
specific but instead coded for a set of related AAs producing a non-degenerate
but functional code. The presence of a primitive code, even an ambiguous code
with a smaller set of AAs, suggests the presence of primitive proteins. 167,168 The
near ubiquitous nature of aaRSs throughout the three kingdoms of life suggests
they are very ancient. If aaRS ancestors existed during the period of this primitive
code, it is plausible that aaRSs may have played a role in AA codification. It is
conceivable that extant aaRS retain recognition features from this era that will be
evident in the selection preference for the prebiotic AAs identified in the early
Earth simulations and meteorite studies.
5.3 Aminoacyl tRNA-Synthetases (aaRSs)
5.3.1 Aminoacyl-tRNA Synthesis
AaRSs are highly specific enzymes that are sentinels of the genetic code.
Researchers have defined a clear two-step mechanism to describe the role of
aaRSs in the selection and subsequent attachment of AAs onto their cognate
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tRNA. The reaction mechanisms for activation and tRNA charging are displayed
in Fig. 31. In the first step (Fig 31A), an aaRS transfers AMP (from ATP) onto an
AA to form a highly energetic mixed anhydride AA-AMP. Next, the aaRSs
attaches the adenylate to the 3’ terminal adenosine of a tRNA. The class II
aaRSs attach the AA directly to the 3’ hydroxyl (Fig 31C). Class I aaRSs initially
attach AAs to the 2’ hydroxyl (Fig. 31B), followed by transesterification to the 3’
hydroxyl (Fig 31D). In vitro studies have shown that aaRSs possess a
discrimination factor of 200 – 10,000 during activation; the stringency factor
increases to > 10,000 during charging.169,170

Figure 31. Aminoacyl-tRNA synthesis
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Two step reaction: (A) Aminoacyl-adenylate formation (B) Transfer of the activated amino acid to the tRNA 3’-CCA
terminus 2’-OH by Class I synthetase. C) Transfer of the activated amino acid to the tRNA 3’-CCA terminus 3’-OH by
Class II. D) 2’-aminoacyl esters undergo a transesterification to the 3’-OH of tRNA.

5.3.2 aaRSs Role in Genetic Code Development
It has been suggested that ancestral aaRSs were initially tasked with
enhancing charging rates in primitive translation with little specificity toward a
particular amino acid.165,171,172 Under this assumption aaRS development could
have followed two possible scenarios: i) aaRSs developed AA specificity in the
presence the genetic code in its current form ii) aaRS specificity coevolved with
the genetic code. The first scenario implies that a fully-fledged genetic code
existed in an RNA based translation system prior to the advent of peptides that
assisted in RNA charging (proto-aaRSs). The second scenario implies the
existence of a primitive genetic code, similar to the operational codes proposed
by Schimmel et. al.168 and Rodin et. al.167,173,174, capable of producing functional
peptides. Further more, it implies that aaRSs were present during the period of
code expansion and/or ambiguity reduction. Under this second scenario, aaRSs
may have played a role in determining the structure of the genetic code. This
may be observable in the interactions between extant aaRSs and AAs,
specifically in the preferential selection (i.e. misactivation) of more ancient AAs
by extant aaRSs. Here, AA misactivation profiles are compared with AA
chronologies based on: AA abundance in early Earth simulations150, AA
biosynthetic pathways147, and physiochemical properties of AAs and
codons/anticodons144. I hypothesize that extant aaRS will show a selection
preference for the prebiotic AAs identified in the early Earth simulations and
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meteorite studies, and for the precursor AAs identified in the AA biosynthesis
study and CET.
5.3.3 Classes of aaRSs
The structures of aaRSs are separated by the different dinucleotide
binding domains of their active sites.134,175-178 The aaRSs from E. coli are listed in
Table 7; each sub-class is color-coded. The majority of bacterial class I aaRSs
are monomeric with the exception of TrpRS and TyrRS; these synthetases are
dimers composed of identical subunits (2 dimers).177,179,180 The majority of
bacterial class II synthetases are 2 dimers, with the exception of GlyRS, PheRS,
and AlaRS. GlyRS and PheRS are 22 tetramers while AlaRS is an 4
tetramer.179,181,182 Fig. 32A and B display the crystal structures of the class I
synthetase GlnRS and class II synthetase AspRS from E .coli. The monomeric
structure of GlnRS183 and dimeric structure of AspRS184 are typical of each class
of synthetase.
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Table 7
The Aminoacyl-tRNA Synthetases of E. coli
Class I

A

Class II

aaRS

Sub-class

Structure

aaRS

Sub-class

Structure

ArgRS

Ia

AlaRS

IIa

CysRS

Ia

a
a

ProRS

IIa

a4
a2

IleRS

Ia

a

SerRS

IIa

a2

LeuRS
MetRS

Ia
Ia

a

ThrRS
HisRS

IIa
IIa

a2

ValRS
GluRS

Ia
Ib

a

GlyRS
AsnRS

IIb
IIb

a2b2

GlnRS
TyrRS

Ib
Ic

a

IIb
IIb

a2

a2

AspRS
LysRS

TrpRS

Ic

a2

PheRS

IIc

a2b2

a
a

a2
a2
a2

B

Figure 32. Crystal structures of class I and II aminoacyl-tRNA synthetases
A) X-ray crystal structure of the monomeric Class I synthetase GlnRS at a resolution of 2.6 Å [PDB: 1NYL]183. B) X-ray
crystal structure of the Class II synthetase AspRS 2 dimer at a resolution of 2.7 Å [PDB: 1EQR]184.

5.3.3.1 Class I aaRSs. Class I synthetases contain a Rossmann fold
nucleotide binding domain within their active sites.179,180,182 A Rossmann fold
is composed of two alternating ---- structural motifs that form a parallel 81

sheet. In aaRSs the fold is slightly altered substituting two ---- motifs
instead.180 The Rossmann fold domains of most class I synthetases contain two
characteristic motifs (KMSKS and HIGH).179,185 The KMSKS and HIGH motifs are
named for their amino acid sequences. The KMSKS and HIGH motifs have been
implicated in the stabilization of the aminoacyl adenylate. 179,185 Certain class I
synthetases contain one or two large connective peptide (CP) insertion domains
(CP1 and CP2) that bisect the Rossmann fold domains, thought to participate in
editing function.186,187 Fig. 33 shows the Rossmann fold of GlnRS from E.coli with
the HIGH and KMSKS motifs are highlighted in green and red.183 The CP1
insertion domain of GlnRS is highlighted in purple.

Figure 33. Class I Rossmann Fold of GlnRS from E.coli
X-ray crystal structure of the class I Rossmann Fold of GlnRS from E.coli at a resolution of 2.6 Å. The HIGH motif is
shown in green, the MSK motif is shown in red, and the CP1 insertion domain is shown in purple [PDB: 1NYL]183.
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5.3.3.2 Class II aaRSs.The structure of class II aaRSs is more varied;
these enzymes contain an atypical anti-parallel -fold nucleotide-binding domain
and three conserved structural motifs.181,182,188,189 Fig. 34 displays these
structural features for AspRS from E. coli.184 Motifs 1, 2, and 3 are highlighted
in red, green, and blue. Each motif has been shown to facilitate the assembly of
the dimer interface and ATP binding site.181,182,188,189 Motif 1 (red) is composed of
a long α-helix and a short β-strand; motif 2 (green) comprises the first two
strands of the anti-parallel β-sheet nucleotide-binding domain and motif 3 (blue)
contains the central strand of the anti-parallel β-sheet followed by a short helix.

Figure 34. Class II Beta Fold of AspRS from E. coli
X-ray crystal structure of the class II Beta Fold of AspRS from E. coli at a resolution of 2.7 Å. Motif 1 is shown in red, Motif
2 is shown in green, and Motif 3 is shown in blue[PDB: 1EQR]184
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Fig. 35 shows a 3 dimensional view of the L-shaped structure tRNAPhe
from yeast.190 Evidence from crystal structures containing tRNA shows a possible
correlation in the way each class of aaRS approaches the tRNA acceptor
stem.191,192 Class I aaRSs approach from the minor groove side leaving the
variable loop (Fig. 35 shown in orange) facing away from the binding site and
toward the solvent. Class II aaRSs, on the other hand, approach the major
groove side resulting in the variable loop facing toward the binding pocket.

Figure 35. An X-ray crystal structure of tRNAPhe from yeast
An X-ray crystal structure of tRNAPhe from yeast at a resolution of 1.93 Å. The acceptor stem is shown in red. The T loop
is shown in green. The D loop is shown in purple. The variable loop is shown in orange. The anticodon loop is shown in
blue with the GmAA anticodon in yellow. [PDB: 1EHZ]190.

While the amino acid and nucleotide binding strategies are fairly well
conserved among each class of aaRS, tRNA binding relies on a more
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complicated set of tRNA structural and chemical features termed identity
elements that seem to be unique to each aaRS.177,191-194 Each tRNA contains a
specific set of identity elements.192 Identity elements are a set of tRNA bases that
are required for recognition by its corresponding aaRS. The primary tRNA
identity elements for all 20 aaRSs from various species have been established
using studies involving site-directed mutagenesis of tRNAs.191-193 A list of the
identity elements found in E. coli tRNAs is shown in Table 8.193 The most
common identity elements are found in the acceptor stem and anticodon loop
(blue and yellow, Fig. 35), but nucleotide residues in the D stem (purple Fig. 35),
T loop (green, Fig. 35), and variable arm have also been shown to be strong
determinants. Several modified bases present in various tRNAs at different
locations have also been established as vital to cognate tRNA
recognition.191,193,194
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Table 8
Known identity elements of E. coli tRNAs

Identity Elements of E. coli
tRNAs
tRNA
Val
Ile
Leu
Met
Cys
Tyr
Trp
Glu
Gln

tRNA Domain
Anticodon Loop
A35, C36

Acceptor Stem
A73, G3:C70
U4:A69
A73, C4:G69

L/G34, A35, U36,
t6A37, A38

A73
A73, U4, A69,
A5:U68
U73, G2:C71,
C3:G70
A73
G73, A1:U72,
G2:C71, G3:C70
G1:C72, U2:A71

U8A14

G34, C35, A36

G15G48,
A13A22

U35
C34, C35, A36
U34, U35, A37

His
Asp
Lys

A73

Asn
Phe

G73
A73

Ala

A73, G2:C71,
G3U70, G4:C69

Thr
Pro
Gly

U12:A23, C29:G41

C34, A35, U36

G73, U1:A72,
G2:C71, G3:C70
A/G73
G73, C72, G2:C71,
A3:U70, C11:G24,
R4:Y69
G1:C72, C2:G71
A73, G72
U73, G1:C72,
C2:G71, G3:C70
C73, G1
G73, G2:C71

Arg
Ser

Other

Y34, U35, G36,
A37, U38
C35, U/G36

G34, G35, U36
G35, G36
C35, C36
Anticodon
G34, U35, C36,
C38
U34, U35, U36,
(mnm5s2U)34
G34, U35, U36
G34, A35, A36,
G27:C43, G28:C42

U11:A24, U13:G22A46, Δ47
G10
A20
C11:G24

G15C48

G10

U20, G44, U45,
U59, U60
G20

X:Y denotes standard Watson-Crick base pairing, XY denotes non-Watson-Crick base pairing, X/Y denotes that either
base can occupy this position, Δ denotes the absence of a residue, L denotes Lysidine, R denotes a purine, Y denotes a
pyrimidine, t6A is threonylcarbamoyl adenosine, mnm 5s2U is 5-methylamino-methyl 2-thiouridine.184,192,193,195,196
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5.3.4 Fidelity of aaRSs
The aaRSs are capable of selecting their cognate amino acid from a
cellular pool of many chemically/structurally similar molecules with high
efficiency, producing mischarging rates of <10-5 errors per charging event.170,197199

Although initial selectivity plays a major role in excluding non-cognate amino

acids, in most cases initial screenings event do not prevent production of
misactivated adenylates. Editing functions that hydrolyze misactivated or
misacylated products supplement substrate selectivity.169,200-204
The double sieve model is widely accepted as the model to describe the
high fidelity of AA activation and tRNA charging.200,203,205 The model proposes
the existence of secondary active sites capable of expelling non-cognate
substrates that subvert the primary active site. Many aaRSs can expel
misactivated AAs before they are charged onto tRNAs – a process referred to as
pre-transfer editing.201-203,206,207 Many aaRSs are also capable of expelling
misacylated tRNAs – a process referred to as post-transfer editing.201,203,207 Pretransfer editing can act in a tRNA independent or tRNA dependent manner to
expel misactivated AAs. Post-transfer editing mechanisms require tRNA to
initiate editing or removal of misacylated AAs from non-cognate tRNAs.
As stated earlier, the initial selectivity of AAs by aaRSs in the activation
step of aa-tRNA synthesis is the focus of this study. This allows us to determine
if certain AAs are structurally or chemically predisposed to reacting with aaRSs.
AAs that are selected by the largest number of aaRSs presumably possess a
biological imprint that suggests this pool of AAs is more ancient AAs. Finally, we
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compare are AA lineage to those from: early Earth simulations, meteorite
composition, the coevolution theory, and AA biosynthetic pathways.
5.4 Radiometric Amino Acid Activation Assay
Several radiometric assays have been developed that provide the
sensitivity and reliability required for an accurate assessment of enzymatic amino
acid activation and tRNA aminoacylation.208-211 Assays that use [3H] or [14C]
labeled amino acids and [32P] labeled tRNAs have shown great success in
measuring steady state and pre-steady state kinetics of AA activation and tRNA
charging.208-211 However, these techniques have drawbacks. Assays that rely on
the radiolabeled amino acid or tRNA to be captured on filter paper or charcoal
are prone to error from product loss on the filters or during washing.202,208,211
Moreover, laborious washing steps are required, resulting in low throughput.
Determining the fraction of activated or aminoacylated product also requires
knowing the aliquot size and quantum efficiency of the scintillation counter on the
filter medium. Moreover, prohibitive levels of [3H] or [14C] labeled amino acids
are required to investigate aaRSs that possess low KM values (high binding
affinity) toward their cognate AA.202,208,211
More recently, sensitive and straightforward assays have been developed
that use [-32P]ATP as a label to monitor activation.208 Fig. 36 shows the
potential pathways of the radiolabel during activation (shown in red). In Step 1
the ATP is esterified to an amino acid to produce an AA-AM[32P]. Step 2 shows
tRNA independent pre-transfer editing of the resulting AA-AMP to yield the free
amino acid and AMP. Using [-32P]ATP allows direct monitoring of ATP, AMP,
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and AA-AMP being consumed or generated in a typical reaction. Products are
separated using thin layer chromatography (TLC), and can be viewed and
measured with the aid of phosphor imaging tools. Compared to other radiometric
methods this process requires fewer steps, employs a much more efficient
means of product separation, and can also been scaled up using a 96 well-plate
format for higher throughput.208

Figure 36. Possible pathways of the activation reaction
Step 1 shows activation of an AA to form AA-AMP. Step 2 illustrates tRNA independent pre-transfer editing resulting in the
AA-AMP.

An illustration of the TLC separation pattern is presented in Fig. 37. The
top spot corresponds to AA-AMP, the middle spot corresponds to AMP, and the
bottom spot corresponds to unreacted ATP. The presence of activation is
characterized by the appearance of AA-AMP with signal intensity above that of a
negative control containing no AA. As shown in Fig. 37 (inset), AA-AMP
concentration can be calculated by dividing the AA-AMP signal by the total signal
to find the percentage of ATP converted to AA-AMP (%AA-AMP) and multiplying
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this percentage by the amount of ATP in the assay. This alleviates the need for
many of the calculations required when using a scintillation counter (i.e quantum
efficiency calculations and decay corrections).

Amino acid

α-P32 ATP

% AA-AMP =

AA-AMP

E. Coli
aaRS

x 100

Aminoacyl adenylate
AA-AMP

Pyrophosphate

.

(AA-AMP + AMP + ATP)
AA-AMP nM = % AA-AMP × ATPTot (nM)

Figure 37. Radiometric activation assay
Top Left) Basic activation reaction showing the alpha-[32P] radio label. Bottom Left) Equation used to calculate %AAAMP. Right) TLC image of activation showing separation of AA-AMP, AMP, and ATP.
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CHAPTER VI - MATERIALS AND METHODS
6.1 Radiometric Assays
6.1.1. Strategy to Identification of Preferentially Activated AAs
Each aaRS was initially examined with its cognate AA as a positive control
and with no AA as a negative control. In order to increase throughput, the α[P32]ATP assay was initially used to measure the activation of L-AAs in subsets
or groups. Each group was incubated with an individual aaRSs. Subsets showing
AA-AMP production were investigated further. Each AA from subsets showing
activation was assayed individually to determine which AAs are activated. Each
AA subset was grouped according to structural and chemical similarity as shown
in Table 9.
6.1.2. AA Classification:
Groups were classified based upon the chemical composition of their
respective R-groups (Table 9). Group one was composed of aliphatic R-groups
(Ala, Gly, Ile, Leu and Val); group two contained amine and carboxamide Rgroups (Arg, Asn, Gln and Lys); group three contained carboxyl R-groups (Asp
and Glu); group four contained hydroxyl R-groups (Ser and Thr); group five
contained aromatic R-groups (Phe and Trp); group six contained
sulfhydryl/methyl sulfide R-groups (Met & Cys); group seven contained cyclic Rgroups (His and Pro). Upon incubation with the aaRS, groups that generated a
measurable signal were investigated further. The identity of the activated AA
within each group was determined by incubating individual AAs with the aaRS of
interest.
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Table 9
AA Groups used in the activation analysis

Fig. 38 displays the activation scheme using alanyl-tRNA synthetase
(AlaRS). Groups 1 and 4 produced an activation signal (i.e. an increase in the
TLC AA-AMP spot) and proceeded to the next stage in the analysis. The
remaining subgroups (2, 3, and 5 – 7 denoted with an x in Fig. 38) showed no
activation (i.e. no AA-AMP) and were not investigated further. Next, analysis of
the individual AAs within subgroups 1 and 4 (step 4) revealed that Gly and Ser
are preferentially selected. The TLC images for the positive control, negative
control, Gly, and Ser assays are displayed in Fig. 39A. Again the AA-AMP is
represented as the fastest migrating species, followed by the AMP, and
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unreacted ATP does not migrate appreciably. The data shown is based on a
minimum of three independent assays.

Figure 38. Activation scheme for alanyl-synthetase (AlaRS)
Step 1 is a positive control to ensure enzyme activity, Step 2 is a set of group assays. Step 3 displays the individual AA
assays. An X denotes no misactivation. Gly and Ser (shown in red) were selected by AlaRS.

Figure 39. TLC results and forward reaction curves for AlaRS
A) TLC images from AlaRS Pos control (Ala), Neg control (no AA), and individual AA assays for Gly and Ser. Time
increases from left to right with lanes 1 – 11 representing 0s, 0.08m, 0.17min, 0.33min, 0.67min, 1.00min, 2.00min,
4.00min, 8.00min, 12.00min, and 20.00min, respectively. B) Forward reaction curve for AlaRS individual AA assays
showing the Pos control in blue, Gly in grey, Ser in green, and the Neg control in red.
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6.2 Measurement of Activation Reaction Rates
Fig. 40 – 51 and Fig. 52 – 61 show the forward reaction curves for the
class I and class II aaRSs, respectively. Recombinant histidine tagged aaRSs
were expressed in E. coli and purified using a nickel affinity column according to
protocols previously reported by Josephson et. al.212 Positive (Pos) and negative
(Neg) controls are shown for each aaRS along with any misactivated AAs.
Tables to the right of each graph display AA-AMP concentrations at 20 min, the
relative initial rates, and the R2 values for each fit. Each data set was fit using
GraphPad© software, according to its behavior, by one of Eq. 4 – 6. Eq. 4 is a
simple linear regression where the AA-AMP concentration (C) is equal to the rate
constant (k) multiplied by time (t). Eq. 5 is an exponential decay function used to
describe a one-phase association model, where CMax is the maximum AA-AMP
concentration, k is the rate constant, and t is time. Eq. 6 is a product inhibition
model used to fit data displaying reversible Michealis –Menton kinetics, where
CMax is the maximum AA-AMP concentration, t is time, kF is the forward rate
constant and kR is the reverse rate constant. Relative initial rates are calculated
from the first derivative of each forward reaction curve. Each graph represents
the average of at least three replicate assays.
Eq. 4 Linear Model
Eq. 5 One-phase Association Model
Eq. 6 Product Inhibition Model
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CHAPTER VII - RESULTS
7.1. Analysis of AA Activation Patterns Using Class I aaRSs:
7.1.1 Analysis of AA Activation Patterns Using ArgRS:
The forward reaction curves for ArgRS misactivation are shown in Fig. 40.
ArgRS showed no activity in the presence of its cognate AA, Arg, but showed
weak misactivation with several noncognate AAs. The presence of tRNA Arg is
known to be required for activation of Arg213, but this is apparently not so for
misactivation of Ala, Ile. Ser, and Thr. ArgRS produced 0.24 – 0.45 nM adenylate
concentrations with Ala, Ile, Ser, and Thr. Ala produced a biphasic activation
profile and had the highest initial rate at 0.026 nM/min.
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Figure 40. Forward reaction curves of ArgRS
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[AA-AMP]
@ 20min
(nM)

Relative
Initial Rate
(nM/min)

R2

Pos

0.03

-

-

Ala

0.45

0.026

0.65

Ile

0.24

0.005

0.50

Ser

0.31

0.010

0.65

Thr

0.37

0.007

0.51

Neg

0.06

-

-

7.1.2 Analysis of AA Activation Patterns Using CysRS:
CysRS showed no activity toward any of the noncognate substrates
examined. Fig. 41 shows the forward reaction curve of the positive control for
CysRS. CysRS produced relatively low concentrations of cognate adenylate
(1.04 nM) and displayed a slow initial rate of 0.21 nM/min.
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Figure 41. Forward reaction curves of CysRS
7.1.3 Analysis of AA Activation Patterns Using IleRS:
The forward reaction curves for IleRS are shown in Fig. 42 - 44. IleRS
activated the second largest number of noncognate substrates of any aaRS
examined. Val, Met, Thr, Glu, Leu, Cys, and Ala were all misactivated by IleRS.
Val, Met , and Thr are shown in Fig. 42. IleRS showed remarkably strong activity
toward Val, exceeding Ile in adenylate production at 20 min. Val, however,
showed a 3-fold reduction in initial rate versus Ile. Met and Thr also produced
relatively high levels of adenylate ( > 2 nM) at 20 min with rates approximately14
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fold less than with Ile. Fig. 43 shows Glu, Leu, Cys, and Ala with the Pos control
in order to illustrate the weak activation displayed with these substrates. Fig. 44
shows a zoomed in view of Glu, Leu, Cys, and Ala reaction curves, and clearly
shows activation above the level of the Neg control.
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Figure 42. Forward reaction curves of IleRS with Val, Met, and Thr
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Figure 43. Forward reaction curves of IleRS with Glu, Leu, Cys, and Ala.
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Figure 44. Forward reaction curves of IleRS with Glu, Leu, Cys, Ala, and Neg
control (zoomed view) without the Pos control.
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7.1.4 Analysis of AA Activation Patterns Using LeuRS:
Forward reaciton curves for LeuRS are shown in Fig. 45 and 46. LeuRS
showed activity toward several noncognate AAs, however, for many of these this
activity was quite weak compared to the cognate AA Leu (Fig. 45). The zoomed
view shown in Fig. 46 shows LeuRS misactivated Cys, Ile, Phe, Val, Ala, and
Asp. Cys showed the highest level of misactivation, producing 2.23 nM of CysAMP at 20 min at an initial rate of 0.229 nM/min. This represents a 6.5 fold
reduction in adenylate concentration and a 37 fold reduction in initial rate versus
Leu.
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Figure 45. Forward reaction curves of LeuRS

99

[AA-AMP]
@ 20min
(nM)

Relative
Initial Rate
(nM/min)

R2

Pos

14.16

8.420

0.88

Cys

2.23

0.229

0.76

Ile

1.66

0.162

0.62

Phe

1.03

0.053

0.70

Val

0.89

0.148

0.64

Ala

0.58

0.082

0.42

Asp

0.57

0.047

0.63

Neg

0.38

-

-

LeuRS

AA-AMP (nM)

3

2

1

0

0

5

10

15

[AA-AMP]
@ 20min
(nM)

Relative
Initial Rate
(nM/min)

R2

Cys

2.23

0.229

0.76

Ile

1.66

0.162

0.62

Phe

1.03

0.053

0.70

Val

0.89

0.148

0.64

Ala

0.58

0.082

0.42

Asp

0.57

0.047

0.63

Neg

0.38

-

-

20

Time (min)
Figure 46. Forward reaction curves of LeuRS (zoomed view)
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7.1.5 Analysis of AA Activation Patterns Using MetRS:
MetRS was the most active aaRS to show no activity toward any of the
noncognate substrates examined. Fig. 47 shows the forward reaction curve of
the positive control for MetRS. MetRS produced relatively high concentrations of
cognate adenylate (14.16 nM) and displayed one of the fastest initial rates at
8.42 nM/min.
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Figure 47. Forward reaction curves of MetRS
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7.1.6 Analysis of AA Activation Patterns Using TrpRS:
TrpRS showed no activity toward any of the noncognate substrates
examined. Fig. 48 shows the forward reaction curve of the positive control for
TrpRS.
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Figure 48. Forward reaction curves of TrpRS
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7.1.7 Analysis of AA Activation Patterns Using TyrRS:
The forward reaction curves for TyrRS are shown in Fig 49. TyrRS
showed noncognate activity toward Cys and Phe. Both Cys and Phe produced
adenylate levels at 20 min comparable to those seen with Tyr, but with drastically
different initial rates. Cys displayed an initial rate of 5.72 nM/min, or about half
that of Tyr. Phe, on the other hand, displayed an initial rate 17 fold lower versus
Tyr.

Figure 49. Forward reaction curves of TyrRS
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7.1.8 Analysis of AA Activation Patterns Using ValRS:
ValRS (Fig. 50 and 51) was the most active aaRS of all those examined,
both in terms of cognate and noncognate activation. ValRS was also the most
promiscuous aaRS, showing activation toward a total of 10 AAs (Ile, Leu, Asp,
Glu, Ala, Ser, Glu, Thr, Met, and Gly). ValRS produced the highest concentration
of cognate adenylate of any aaRS at 25.79 nM and displayed the highest initial
rate of cognate activation at 88.64 nM/min. Fig. 50 shows ValRS misactivated
five non-cognate AAs (Ile, Leu, Asp, Glu, and Ala) to a higher degree, in terms of
adenylate production, than their respective aaRSs. One non-cognate substrate,
Ile, produced adenylate concentrations 20% higher than with Val. The initial
activation rate with Ile, however, was 6 fold less compared to Val. Ser, Glu, Thr,
and Met ( Fig. 51) showed weaker, but still substantial activation.
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Figure 50. Forward reaction curves of ValRS with Ile, Leu, Asp, Cys, and Ala
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Figure 51. Forward reaction curves of ValRS with Ser, Glu, Thr, Met, and Gly
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7.2. Analysis of AA Activation Using Class II aaRSs:
7.2.1 Analysis of AA Activation Using AlaRS:
Fig. 52 shows the forward reaction curves and accompanying data table
for AlaRS. AlaRS showed strong activity toward Gly and Ser. Both noncognate
substrates produced adenylate concentrations comparable to the cognate Ala at
20 min. Initial rates, however, were 6 – 9 fold lower with Ser and Gly,
respectively, versus Ala.
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Figure 52. Forward reaction curves of AlaRS
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7.2.2 Analysis of AA Activation Using AsnRS:
Fig. 53 shows the forward reaction curves for AsnRS misactivation.
AsnRS was shown to misactivate the two acidic AAs, Asp, and Glu. Asp
produced just under half that of the Pos control with an initial rate 18-fold less
than the Pos control. AsnRS activated Glu much less efficiently, producing an
AA-AMP concentration 10-fold less than the Pos control at an 80-fold lower initial
rate.
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Figure 53. Forward reaction curves of AsnRS
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7.2.3 Analysis of AA Activation Using AspRS:
AspRS forward reaction curves are shown in Fig. 54. AspRS displayed no
cognate activation with Asp (Pos control). AspRS did, however, misactivate Ala,
Gly, and Ser. Misactivated adenylate concentrations at 20 min were relatively low
(1.0 – 0.3nM). Ala showed the highest AA-AMP concentration at 1.09nM with an
initial rate of 2.41 nM/min.
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Figure 54. Forward reaction curves of AspRS
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7.2.4 Analysis of AA Activation Using GlyRS:
GlyRS showed a surprising level of substrate flexibility, though it was one
of the least active aaRSs, producing only 0.31 nM Gly-AMP at 20 min. Fig. 55
shows Ala and Met misactivation produced nearly 50% higher adenylate
concentrations at 20 min versus Gly, and Ser was misactivated to nearly the
same degree as Gly. Initial rates for GlyRS were relatively low with Ala producing
the highest initial rate at 0.55 nM/min.
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Figure 55. Forward reaction curves of GlyRS
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7.2.5 Analysis of AA Activation Using HisRS:
HisRS was the only class II aaRS to show no activity toward any of the
noncognate substrates examined. Fig. 56 shows the forward reaction curve of
the positive control for HisRS. HisRS produced very low concentrations of
cognate adenylate (0.48 nM) but at a significant initial rate of 6.64 nM/min.

Figure 56. Forward reaction curves of HisRS
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7.2.6 Analysis of AA Activation Using LysRS:
LysRS forward reaction curves are shown in Fig. 57. LysRS was one of
the most active of the class II aaRSs with the highest initial rate of cognate
activation of any class II aaRS. LysRS produced a biphasic activation profile with
Lys with an initial rate exceeding 20 nM/min. LysRS showed noncognate activity
toward Ile, Cys, and Met. All produced relatively high adenylate concentrations at
20 min, however, at rates 20 – 55 fold lower rates versus Lys.
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Figure 57. Forward reaction curves of LysRS
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7.2.7 Analysis of AA Activation Using PheRS:
PheRS showed moderate activity toward Tyr. The forward reaction curves
for PheRS are shown in Fig. 58. Tyr produced only 3 fold less adenylate
concentration at 20 min, but displayed an initial rate 11 fold lower versus Phe.
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Figure 58. Forward reaction curves of PheRS
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7.2.8 Analysis of AA Activation Using ProRS:
The forward reaction curves for ProRS are shown in Fig 59. ProRS was
shown to misactivate Ala. Ala misactivation produced an almost 10 fold reduction
in both adenylate concentration at 20 min and in initial rate versus the cognate
substrate Pro.
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Figure 59. Forward reaction curves of ProRS
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7.2.9 Analysis of AA Activation Using SerRS:
SerRS was shown to misactivate Cys. The forward reaction curves
showing activation profiles for the Ser (pos) and Cys are shown in Fig. 60. Initial
activation rates show Cys was activated 50 fold less efficiently than the cognate
Ser.
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Figure 60. Forward reaction curves of SerRS
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7.2.10 Analysis of AA Activation Using ThrRS:
ThrRS (Fig. 61 and 62) showed activity toward the highest number of
noncognate substrates of any class II aaRS. ThrRS misactivated Ala, Gly, Ile,
Ser, and Cys. Ala was misactivated 3 – 4 fold less efficiently than Thr both in
terms of adenylate produced at 20 min and initial rate. Gly, Ile, Ser, and Cys
were activated much less efficiently, producing adenylate concentrations 10 fold
less than with Thr and at initial rates 20 – 100 fold slower.
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Figure 61. Forward reaction curves of ThrRS
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Figure 62. Forward reaction curves of ThrRS (zoomed view)

7.3 Analysis of AA Misactivation
Table 10 shows a summary of class I aaRS activation with aaRSs listed
horizontally and AAs listed vertically. Both are arranged in order of highest
number of misactivations. An X denotes activation of an AA by an aaRS. Five
class I aaRSs (ArgRS, IleRS, LeuRS, TyrRS, and ValRS) misactivated at least
one non-cognate aaRS. An additional three (CysRS, MetRS, and TrpRS) showed
only cognate activation. Two class I aaRSs (GlnRS and GluRS) produced no
activation (calibration curves for these two aaRSs are not shown). While only five
of ten class I aaRSs showed noncognate activity, several of these misactivated a
large number of AAs with varying side chain functionalities. A subset of closely
related class Ia aaRSs comprised of ArgRS, IleRS, LeuRS, and ValRS, showed
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a great deal of substrate flexibility, misactivating aliphatic, hydroxyl containing,
acidic, sulfur containing, and aromatic AAs.
Table 10
Summary of class I aaRS activation
Class I aaRSs
Cys
Ala
Ile
Thr
Val
Leu
Met
Asp
Glu
Ser
Phe
Gly
Tyr
Trp
His
Lys
Pro
Arg
Asn
Gln

ValRS
x
x
x
x
x
x
x
x
x
x

IleRS
x
x
x
x
x
x
x

LeuRS
x
x
x

ArgRS

TyrRS
x

TrpRS

CysRS
x

MetRS

GluRS

GlnRS

x
x
x

x
x
x
x

x
x
x

x

x
x
x

Table 11 shows a summary of class II aaRS activation with aaRSs listed
horizontally and AAs listed vertically. Again, both are arranged in order of highest
number of misactivations with an X denoting activation. Nine class II aaRSs
(AlaRS, AsnRS, AspRS, GlyRS, LysRS, PheRS, ProRS, SerRS, and ThrRS)
misactivated at least one non-cognate AA. HisRS showed only cognate
activation. Class II aaRSs showed non-cognate activation to nine AAs (Ala, Ser,
Gly, Cys, Ile, Met, Asp, Glu, and Tyr), and were also shown to preferentially
select aliphatic, hydroxyl containing, acidic, sulfur containing, and aromatic AAs.
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Table 11
Summary of class II aaRS activation
Class II aaRSs
Ala
Ser
Gly
Cys
Ile
Met
Asp
Glu
Tyr
Thr
Leu
Asn
His
Phe
Lys
Pro
Arg
Gln
Trp
Val

ThrRS
x
x
x
x
x

GlyRS
x
x
x

x

LysRS

AlaRS
x
x
x

AspRS
x
x
x

AsnRS

PheRS

ProRS
x

SerRS

HisRS

x

x
x
x

x

x
x
x
x
x
x
x
x
x

Tables 12 and 13 show AAs selected during class I and II aaRS assays
listed as “Early” with those rejected listed as “Late”. These tables are based on
the hypothesis that early AAs are more highly selected by extant aaRSs for
misactivation. For both data sets, the list of early AAs contains a near equal
number of AAs specific to both classes of aaRSs. Aliphatic AAs (Ala, Ile, Leu,
and Val), hydroxyl containing (Ser and Thr), sulfur containing (Cys and Met), and
acidic AAs (Asp and Glu) were selected to a high degree and placed in the Early
column. The aromatic AA Phe was misactivated by a single class I aaRS, TyrRS,
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and tentatively placed in the Early column. All amide and carboxamide containing
AAs (Arg, Asn, Gln, and Lys) are placed in the Late column.
Table 12
Early vs. Late AAs according to class I aaRS misactivation
Class I Chronology
Early
Late
Cys
Tyr
Ala
Trp
Ile
His
Thr
Lys
Val
Pro
Leu
Arg
Met
Asn
Asp
Gln
Glu
Ser
Phe
Gly

Table 13
Early vs. Late AAs according to class II aaRS misactivation
Class II Chronology
Early
Late
Ala
Thr
Ser
Leu
Gly
Val
Cys
Phe
Ile
His
Met
Lys
Asp
Pro
Glu
Trp
Tyr
Arg
Asn
Gln
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CHAPTER VIII - DISCUSSION AND CONCLUSION
8.1 Discussion
Tables 14 A-C show Early vs. Late AAs based on three of the theories
discussed earlier. AAs sharing the same box are equal in age according to each
theory. Table 14A is derived from a consensus of proteinacious AAs found in
early Earth simulations.137,138,150 Table 14B is derived from the codon-ceding
scheme proposed in the CET.147 Table 14B shows the results from a consensus
study examining a set of criteria thought to be associated with AA age. 144 This
study determined an AA chronology based primarily on thermodynamic stability
and cost of proccessivity. In this study, AAs that are most thermally stable and
least costly to process were considered to be early AAs. Table 15 shows a
consensus table derived from Tables 12 and 13 from the current study. AAs
activated by at least two noncognate aaRSs are considered early. AAs showing
only a single instance of misactivation along with those showing no misactivation
are considered late. There is a consensus between all chronologies for a majority
of AAs. Ala, Ser, Gly, Asp, Glu, Thr, Leu, and Val are considered early by all
methods. Likewise, Arg, Asn, His, Lys, Tyr, and Trp are considered late by each
method. Data for Cys, Gln, Ile, Met, Phe, and Pro do not agree between
methods.
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Table 14 AA
Chronologies based on early Earth/meteorite studies, Physiochemical Properties,
and Biosynthetic Pathways

Table 15
Consensus AA Chronology Based on Class I and II aaRS Activation

To further illustrate the compliance of misactivation profiles with the CET
and AA biosynthetic pathways, Fig. 63 and 64 were generated showing the
misactivation overlaid onto a schematic of extant biosynthetic pathways (Fig. 63)
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and the codon-conceding scheme proposed by Wong in the CET (Fig. 64). When
the AA misactivation data from the current study is overlaid onto the AA
biosynthetic pathways all of the most highly misactivated AAs (early AAs)
comprise all of the inner nodes. These are shown in dashed red boxes in Fig. 63.
AAs showing little or no misactivation are all termination points in the pathways,
shown in solid blue boxes in Fig. 63. In the biosynthetic pathways shown here all
intermediate precursor AAs are from the group of highly misactivated AAs (Early
AAs). AAs showing little or no misactivation (Late AAs) are not precursors of
other AAs. This illustrates the selection preference of extant aaRSs for AAs that
are precursors of other AAs and closer to central metabolism. Assuming that
precursor AAs and AAs closer to central metabolism are more ancient suggests
that extant aaRSs may have retained some activity toward their ancestral
substrates (i.e. early AAs) and may suggest a role for ancestral aaRSs in
primitive biosynthesis of AAs or their intermediates.
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Early

Late

Figure 63. AA misactivation vs. AA biosynthetic pathways
AA biosynthetic pathways with AA misactivation results overlaid onto it. Highly misactivated or Early AAs are shown in
dashed red boxes. AAs showing little or no misactivation are shown in solid blue boxes. From “Amino acid biogenisis,
evolution of the genetic code and aminoacyl-tRNA synthetases,” by Klipcan et. al.2004. J. Theor. Biol. 228, 389-396.
Copyright 2004 by Elsevier. Reprinted with permission of the author.146

Fig. 64 was generated, showing the codon-conceding scheme proposed
by Wong in the CET with the AA misactivation results overlaid onto it. The figure
shows the proposed evolution of AA codification as codons are conceded from
older AAs to newer, AAs. In this case the group of highly misactivated AAs (Early
AAs) again comprise all of the inner nodes. AAs considered Late according to
misactivation data are terminal points according to this scheme. The correlation
between the AA selectivity of aaRSs and the codon concession scheme shown in
Fig. 64 suggests that aaRS may have played a role in AA codification. If extant
123

aaRSs have indeed retained activity toward a set of early AAs, this suggests that
development of aaRS specificity may be linked to the codon concession process.

Early

Late

Figure 64. AA misactivation vs. CET
Codon ceding scheme proposed in the CET with AA misactivation results overlaid onto it. Highly misactivated or Early
AAs are shown in dashed red boxes. AAs showing little or no misactivation are shown in solid blue boxes. From “A coevolutiontheory of the genetic code,” by Wong 1975, Proc. Nat. Acad. Sci. 72, 1909-1912. Copyright 1975 by Proc. Nat.
Acad. Sci. Reprinted with permission of the author.147

There seems to be little relationship between aaRS class and selection of
AAs for misactivation. Overall, AAs are not selected to a higher degree by aaRSs
of their respective classes. Six class I specific AAs (Cys, Ile, Val, Leu, Glu, and
Met) were misactivated by class I aaRSs. Additionally, five class II specific AAs
(Ala, Asp, Ser, Thr, and Phe) were activated by class I aaRSs. Only four of ten
class II specific AAs (Ala, Ser, Gly, and Asp) showed misactivation by the class II
aaRSs. Class II aaRSs showed noncognate activity toward five class I specific
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AAs (Cys, Ile, Met, Glu, and Tyr). The class II aaRSs proved to be more
promiscuous as a group than the class I aaRSs. Nine of the ten class II aaRSs
showed activity toward at least one noncognate substrate compared to only five
of ten class I aaRSs. However, a subset of class I aaRSs (ArgRS, IleRS, LeuRS,
and ValRS) showed a high degree of substrate flexibility, and activated a higher
number of AAs. Both classes showed a propensity for excluding many of the
same AAs. Arg, Asn, Lys, and Gln, AAs containing amide or carboxamide side
chains, were completely rejected for misactivation.
8.2 Conclusion
The data presented in this study suggests that extant aaRSs have a
selection preference for AAs thought to be among the most ancient. AA
misactivation profiles shown in Fig. 40-62 and summarized in Tables 11-12
correlate with the many of the current theories on the evolution of AA recruitment
and codification, including the CET (Fig. 64). This points to the prospect that
aaRSs may have played a role in the process of AA codification during some
phase of genetic code development. This proposition depends heavily on the
state of the genetic code during the transition from ribozyme-based translation to
protein-based translation when the ancestors of aaRSs first took up the role of
tRNA charging.
It has been suggested that ancestral aaRSs were initially tasked with
enhancing charging rates in primitive translation with little specificity toward a
particular amino acid.167 The diversification of aaRS into AA specific enzymes
could have followed two possible scenarios: i) aaRSs initially developed AA
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specificity in the presence the genetic code in its current form or ii) aaRSs initially
developed in the presence of an incomplete set of AAs and AA specificity
coevolved with the genetic code. The first scenario implies that a fully-fledged
genetic code existed in an RNA based translation system prior to the advent of
peptides that assisted in RNA charging (proto-aaRSs). The second scenario
implies the existence of a primitive genetic code similar to the operational codes
proposed by Schimmel and Rodin 167,168,173,174, capable of producing functional
peptides. Furthermore, it implies that aaRSs were present during a period of
code expansion and ambiguity reduction.
The results of this study suggest the second scenario to be more likely
and support the supposition that ancestral aaRSs were initially tasked with
enhancing charging rates in primitive translation with little specificity toward a
particular amino acid. Many extant aaRSs display noncognate activity toward
AAs thought to be among the earliest. This activity may be a vestige of ancestral
aaRS specificity toward this group of AAs. If this is indeed the case, it indicates
that ancestral aaRSs arose during a period of an early operational code with
fewer than 20 AAs (i.e. the set identified as early AAs) and were present during
later stages of genetic code development.
Further, the selection (or misactivation) profiles of extant aaRSs suggest
that interactions between ancestral aaRSs and AAs may have played a role in
AA recruitment and in determining the structure of the genetic code. This
scenario is evidenced by the synthesis of Gln-tRNAGln observed in archea and
certain bacteria that lack GlnRS132. In these organisms GluRS forms an
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intermediate of Gln-tRNAGln by mischarging tRNAGln with Glu to form GlutRNAGln.132,214,215 The Glu moiety is then converted to Gln by an
amidotransferase.132,215 In this manner GluRS participates in the synthesis of an
intermediate of Gln. The ability of GluRS to charge both tRNAGlu and tRNAGln with
Glu also provides a mechanism for codon concession that is linked to aaRS
specificity.
In a manner similar to GluRS, ancestral aaRSs may have participated in
the synthesis of new AAs and conceded codons to them, thereby directing the
recruitment and coding of AAs. The AA selection profiles from this study show
that extant aaRSs preferentially misactivate AAs thought to be more ancient,
suggesting that aaRSs may still hold a vestige of their ancestral activity toward
an early set of AAs. This apparent prefernce for an ancient set of AAs suggests
that aaRSs origionally developed specificity for this ancient set of AAs and points
to the likelihood that aaRSs played a part in AA synthesis and codification during
a period of expansion and ambiguity reduction of the genetic code.
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